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High blood pressure blood pressure is an important risk factor for cardiovascular
disease and affects almost one-third of the U.S. adult population. Historical cuff-less
non-invasive techniques used to monitor blood pressure are not accurate and highlight
the need for first principal models. The first model is a one-dimensional model for pulse
wave velocity (PWV) propagation in compliant arteries that accounts for nonlinear fluids
in a linear elastic thin walled vessel. The results indicate an inverse quadratic
relationship (R2 = .99) between ejection time and PWV, with ejection time dominating
the PWV shifts (12%). The second model predicts the general relationship between
PWV and blood pressure with a rigorous account of nonlinearities in the fluid dynamics,
blood vessel elasticity, and finite dynamic deformation of a membrane type thin
anisotropic wall. The nonlinear model achieves the best match with the experimental
data. To retrieve individual vascular information of a patient, the inverse problem of
hemodynamics is presented, calculating local orthotropic hyperelastic properties of the
arterial wall. The final model examines the impact of the thick arterial wall with different
material properties in the radial direction. For a hypertensive subject the thick wall
model provides improved accuracy up to 8.4% in PWV prediction over its thin wall
counterpart. This translates to nearly 20% improvement in blood pressure prediction
based on a PWV measure. The models highlight flow velocity is additive to the classic
pressure wave, suggesting flow velocity correction may be important for cuff-less, noninvasive blood pressure measures. Systolic flow correction of the measured PWV
improves the R2 correlation to systolic blood pressure from 0.81 to 0.92 for the mongrel
dog study, and 0.34 to 0.88 for the human subjects study. The algorithms and insight
resulting from this work can enable the development of an integrated microsystem for
cuff-less, non-invasive blood pressure monitoring.
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Chapter 1:

Introduction

A wave may seem like a simple thing, but in fact it is the most complicated form in nature. - Susan Casey

1.1. Abstract
This chapter motivates the importance of continuous noninvasive monitoring of
blood pressure and arterial compliance. It reviews historical techniques used or
attempted to date. The review highlights the need for first principle models to gain the
insight required to improve continuous blood pressure monitoring. The goals of this
work are to develop the models, understand the fundamental nature of pulse wave
propagation in arteries, and enable the development of an integrated microsystem for
continuous noninvasive blood pressure monitoring.
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1.2. Nomenclature
cMK
E
h 0, h
H
L
r
r0
p
ρ

PTT
PWV
𝜈
Subscripts

0

Moens-Korteweg speed of propagation (m/s)
Modulus of elasticity (Pa)
Thickness of the wall in zero-stress and deformable conditions, respectively (m)
Ratio of the wall deflection to r0
1D final length (m)
Radius (m)
Radii in a zero-stress condition (m)
Pressure (Pa)
Density of incompressible fluid (kg/m3)
Pulse transit time (s)
Pressure wave velocity (m/s)
Poisson’s coefficient
Initial
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1.3. Introduction
Hypertension, or high blood pressure, is an important risk factor for cardiovascular
disease and affects almost one-third of the U.S. adult population [1]. In 2009-2010,
nearly 82% of adults with hypertension were aware of their status, and nearly 76% were
taking medication [2]. Despite considerable improvement in increasing the awareness,
treatment, and control of hypertension, undiagnosed and uncontrolled hypertension
among minority groups remains a challenge [3,4,5]. During 2011-2012, among adults
with hypertension, 82.7% were aware of their hypertension, 75.6% reported currently
taking prescribed medication to lower their blood pressure, and 51.8% had their blood
pressure controlled. The prevalence of hypertension increased with age, from 7.3%
among those aged 18-39, to 32.4% among those 40-59, to 65% among those 60 and
over [6]. The ability to create a continuous noninvasive microsystem to improve
awareness, treatment, and control of hypertension is the long-term goal of this work.
Research conducted in 1955 by Thomas et al. [7], tried to use the arterial pulse
wave to measure blood pressure. The pulse wave, generated by left ventricular ejection,
propagates at a velocity that has been identified as an important marker of
atherosclerosis and cardiovascular risk [8-16]. Cardiovascular disease affects 37% of
the United States population and is the leading cause of death [8]. Increased pulse
wave velocity (PWV) indicates an increased risk of stroke and coronary heart disease
[9]. This velocity is considered a surrogate marker for arterial compliance [10], is highly
reproducible [10], and is widely used to assess the elastic properties of the arterial tree
[11]. Research shows that aortic compliance measurement using PWV could allow for
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early identification of patients at risk for cardiovascular disease [8,10,14]. The ability to
identify these patients would lead to better risk stratification and earlier, more costeffective preventative health intervention [12].
Pulse transit time or PWV has also been measured in various research studies as a
method to continuously monitor blood pressure [21-23]. Hypertension is defined as a
chronic condition in which blood pressure is above 140 mmHg/90 mmHg
(systolic/diastolic) [13]. Hypertension increases the risk for stroke, coronary heart
disease, congestive heart failure, and renal disease [11,17]. Blood pressure has been
shown to vary up to 20% in a 24-hour period due to circadian rhythms [14]. It is also
variable in the clinic where “white coat” and “masked” hypertension can lead to
misdiagnosis of high blood pressure [15]. This variation highlights the need for
continuous blood pressure monitoring, which is not achieved with occasional
measurement that occurs with “at-home cuff”-based oscillometric monitors. If a
continuous noninvasive blood pressure monitor were available, it would be possible to
track long-term trends and allow for lifestyle and/or medication adjustments.
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1.4. History of PWV used for Continuous Noninvasive Blood
Pressure
The Moens-Korteweg (cMK) equation (1.1) was derived in 1878 from the wave
equation for the velocity of propagation in meters per second of a pressure impulse
within a thin-walled, perfectly elastic (𝑣=0.5), cylindrical tube [27,28].

𝐸ℎ
𝑐 = 𝑐𝑀𝐾 = √
2𝑟0 𝜌

(1.1)

𝐸 is the elastic modulus for the wall, 𝐸̅ = 𝐸/(1 − 𝜈 2 ), 𝑣 is Poisson’s coefficient, h is the
constant thickness of the wall, and r0 is the cross-sectional radius of the unstressed
cylindrical vessel at zero pressure (𝑝 = 0). Details of the derivation were reviewed by
Hardung [16]. Young’s modulus in this equation is the static modulus of elasticity at zero
pressure. Experimental research has proven that the modulus of elasticity does, in fact,
change dynamically; therefore, Hughes et al. empirically modified the cMK equation to
reflect this observation [21,28]. Hughes et al. [17] defined the dynamic Young’s modulus
as:

𝐸 = 𝐸𝑒 𝛼𝑝

(1.2)

where: α is a vessel coefficient, and p is pressure (Pa). The vessel coefficient was
selected to match a specific canine’s excised aorta based on a single plot of static
pressure versus Young’s modulus. Chen et al. [18] extended this work to derive an
equation for pressure, as shown in equation (1.3).

24

1
𝜌2𝑟𝐿2
𝑝 = [𝑙𝑛 (
) − 2𝑙𝑛𝑇𝑇]
∝
ℎ𝐸0

(1.3)

where: ρ is the density of blood, r is the radius of the artery at a respective pressure, L
is the length between the two pulse measurement points, and TT is the true transit time
for the pulse to propagate between the two measurement points. While this provides
more accurate results than using a static Young’s modulus, it is not derived from first
principles, and it misses important variables that influence blood pressure. In addition,
the parameters required (E0, h, r) are difficult to measure.
Several studies have shown the influence of blood pressure [8,19,20,30] and left
ventricular ejection time (LVET) [11, 19] on PWV. Nurnberger et al. [11] used
myocardial stimulation to modulate ejection time and measure the associated change in
PWV that was found to correlate only with LVET (R2 = 0.52, p = 0.0325). In their study,
a change in ejection time of ~40 ms caused a change of PWV of ~1 m/s. Salvi et al. [19]
performed a large population study to explore the link between PWV and LVET. An
inverse association was found between PWV and LVET at all ages (<R2 = 0.43;
p < 0.001). In both studies, it was not possible in vivo to control LVET, systemic
vascular resistance (SVR), and ejection volume, which likely decreased their observed
correlation. The clinical relationship between PWV and arterial stiffness is often based
on classic linear models [32,33] or the combination of the linear models and measured
results with an incorporated correction factor [21,28,35]. Whereas linear models predict
PWV as a function only of the geometric and physical properties of the fluid and the
wall, there is strong evidence that PWV is also correlated with pressure [19,20,30] and
ejection time [14,19].
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1.5. Objectives and Goals of the Work
While both pressure and LVET are clinically shown to affect PWV, a predictive
model that provides mechanistic insight and incorporates peak pressure, ejection time,
ejection volume, and modulus of elasticity has yet to be developed. The aim of this work
is to develop and validate a model to provide this missing insight. The approach used is
based on a one-dimensional nonlinear model for pressure wave propagation in a
compliant tube with a linear elastic wall filled with an incompressible fluid. The model
incorporates the classical solitary wave-based solution, connecting speed of
propagation to the ejection time, ejection volume, and peak pressure, accounting for
nonlinear wave propagation effects, elastic deformable vessels, and the inertia of the
distensible vessel walls. The model is validated using a physiologically based
electromechanical hemodynamic simulator.
A number of researchers have used pulse arrival time (rPTT) or true transit time
(TT) to try to estimate systolic blood pressure (SBP) and diastolic blood pressure (DBP).
The results have not met the accepted Association for the Advancement of Medical
Instrumentation (AAMI) standards for accuracy using the standard cuff-based approach.
These results have even caused some researchers to conclude that pulse transit time
measured from the ECG is an unreliable marker of beat-to-beat blood pressure [20].
Existing systems fail to measure blood pressure accurately across population and
activity level. The second aim of this work is to develop a model that predicts the
general relationship between PWV and blood pressure (BP) with a rigorous account of
nonlinearities in the fluid dynamics model, blood vessel elasticity, and finite dynamic
deformation of a membrane-type thin anisotropic wall. Using this model, we aim to
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develop a per patient calibration (4-point) using parametric optimization and NelderMead optimization. This model is validated using existing clinical studies. Finally, the
model is used to predict SBP/DBP after an initial per patient calibration.
This work focused on understanding the fundamental nature of pulse wave
propagation in arteries that can be integrated into wearable microsystems technologies.
PWV and ECG are two of the physiological signals required. While today’s wearables
have integrated photoplethysmography as a way to measure heart rate, they have yet to
extend and combine the necessary measures to extract PWV. Companies like AlivCor
have created smartphone sensors that enable ECG measurement; however, the
sensors are not yet in a wearable form. In addition to these measures, a measure of
pre-ejection period and flow are required. Multiple approaches show promise, such as
the ballistocardiogram (BCG), impedance plethysmography, inductive sensing, RF
techniques such as dual-antenna nanosecond pulse near-field sensing (NPNS), and
micro-ultrasound sensors [35]. As of this writing, none of these techniques has yielded a
wearable technology and been validated across various physiological states against a
gold standard (Doppler ultrasound). The combination of ECG, PWV, and flow measures
is required in a wearable microsystem to allow for cuff-less, continuous non-invasive
blood pressure monitoring.
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1.6.

Thesis Organization

This thesis is organized into the following chapters:
Chapter 2 reviews the background of fluid dynamics as it relates to pulsatile
pressure and flow in a cylindrical tube or artery. One-dimensional (1D) and twodimensional (2D) stress-strain relationships are considered. The basic stress-force
relationships are covered without accounting for deformation. Building upon this
information, the 2D linear vessel is reviewed. Special attention is given to define both
the axial and longitudinal stress. The focus is then shifted to consider the effects of
nonlinearity. Considering the effect of deformation, Cauchy-Euler, Piola-Lagrange, and
Kirchoff stresses are defined and related.
Chapter 3 begins with a background of fluid dynamics as it relates to pulsatile
pressure and flow in a cylindrical tube or artery. Using that foundation, the effect of
nonlinear fluids on a linear elastic thin-walled vessel is derived. This work creates a
one-dimensional model for blood pressure wave propagation in compliant arteries that
accounts for nonlinear fluids in a linear elastic thin-walled vessel. This model is then
validated using an in-vitro simulator. The in-vitro physiological electromechanical
cardiovascular simulator used for the validation is described in detail. There is a
complete review of the theoretical and measured results. The chapter concludes with a
description of the mechanisms causing the association between PWV and LVET.
Specifically, it describes how the model incorporates the classical solitary wave-based
solution, connecting speed of propagation to the ejection time, ejection volume, and
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peak pressure, accounting for nonlinear wave propagation effects, elastic deformable
vessels, and the inertia of the distensible vessel walls.
Chapter 4 presents a novel approach to PWV prediction in compliant arteries. In
this chapter, the nonlinear contributions of finite deformation, hyperelasticity, fluid
convective phenomena, and longitudinal pre-stress are analyzed and used to extend
the 1D model presented in Chapter 3. The model is then validated across available invivo experimental data. Specifically, it is compared to Histand-Anliker and MuehlsteffSchett using a 4-point calibration technique. The impact of different nonlinearities on a
quality of the best fit is analyzed. In addition, the topology of the Least Square as a
function of material properties (c, a11, a12, a22) is presented. We specifically compare our
model results for Histand-Anliker to Zhou-Fung’s five mongrel dogs. The chapter
concludes with an explanation of steps necessary for a per person calibration to
generate a predictive PWV versus pressure curve that can be used in non-invasive BP
measurement.
Chapter 5 extends the model further to consider the effect of a thick multilayered
arterial vessel. The goal of this chapter is to re-examine the accuracy of PWV prediction
based on traditional homogeneous structural models for thin-walled arterial segments.
In reality, arterial walls are heterogeneous composite structures formed of three clearly
defined layers. An essential ingredient is the notable dependence of results on
nonlinear aspects of the model: convective fluid phenomena, hyperelastic constitutive
relation of each layer, and finite deformation. The contribution of each of the
nonlinearities is analyzed.
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Chapter 6 uses the model developed in Chapter 5, in which a physics-based
mathematical model of PWV that explains flow velocity is additive to the classic
pressure wave as estimated by arterial material properties, suggesting that flow velocity
correction may be important for cuff-less non-invasive blood pressure measurements.
The developed model allows us to understand the impact of systolic flow correction of
measured PWV on systolic blood pressure prediction accuracy using data from two
published in vivo studies. Both studies examined the relationship between PWV and
blood pressure under pharmacological manipulation, one in mongrel dogs and the other
in healthy adult males. The results support the hypothesis that systolic flow correction is
an essential element of non-invasive, cuff-less blood pressure estimation based on
PWV measures.
Chapter 7 summarizes the conclusions and describes opportunities for future
work.
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Chapter 2: Elements of Linear and
Nonlinear Theory of Elasticity
You must do things you think you cannot do. - Eleanor Roosevelt

2.1.

Abstract

This chapter reviews fluid dynamics as it relates to pulsatile pressure and flow in
a cylindrical tube or artery. One-dimensional and two-dimensional stress-strain
relationships are considered. The basic stress-force relationships are covered without
accounting for deformation. Based on this information, the 2D linear vessel wall is
reviewed. Special attention is given to define both the axial and longitudinal stress. The
focus is then shifted to consider the effects of nonlinearity. Considering the effect of
deformation, Cauchy-Euler, Piola-Lagrange, and Kirchoff stresses are defined and
related. The background information is then expanded for the three different models
described in Chapters 3-5.
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2.2.
E
F
G
h 0, h
L
ΔL
p
r
S
T
u
W
ε
ρ
η
𝜎
λ

ν

Nomenclature
Modulus of elasticity (Pa)
Force (N)
Green strain (Pa)
Thickness of the wall in zero-stress and deformable conditions, respectively (m)
1D length (m)
Elongation (m)
Transmural pressure (Pa)
Radius (m)
Kirchoff stress (Pa)
Piola-Lagrange stress (Pa)
Axial flow velocity (m/s)
Potential energy (J)
Strain
Density of an incompressible fluid (kg/m3)
Circumferential wall strain
Cauchy stress (Pa)
Stretch ratio
Poisson’s coefficient

Subscripts

10,20,30
1,2,3

Initial coordinate independent measure; for Cartesian, it would be a measure in the
x,y,z directions, respectively
Final coordinate independent measure; for Cartesian, it would be a measure in the
x,y,z directions, respectively
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2.3.
Introduction of Elements of Linear and Nonlinear Theory of
Elasticity
When inelasticity, anisotropy, and nonlinearity are coupled, the problem of how to
describe the mechanical properties of arteries in a simple and accurate mathematical
form becomes quite acute [1]. In this chapter, the 1D and 2D stress-strain relationships
are defined. This information is extended to understand the stress-force relationship on
a simple 3D object. In order to tie the information back to a simple artery, a 2D linear
vessel is covered. The effect of axial and circumferential deformation is described as a
way to introduce nonlinearity to the system. This information is used as the foundation
for the one-dimensional models for blood pressure wave propagation in compliant
arteries.

2.3.1. Stress and Strain in 1D Linear Mechanics
A one-dimensional object stretched in the x-direction (shown in Figure 2.1) has an
original length L0, and a final length after force is applied in the x-direction of L.

F1

L0

∆L

L

Figure 2.1. 1D object with an initial length L0 and a final length of L after a forceF1 is applied.

The stretch ratio and elongation are defined as

λ=

𝐿
𝐿0

(2.1)
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ΔL = L − 𝐿0

(2.2)

The ratio of ΔL to L0 defines strain as a function λ according to

𝜀=

ΔL 𝐿 − 𝐿0
=
=𝜆−1
𝐿0
𝐿0

(2.3)

Hooke’s Law now relates stress to strain by the modulus of elasticity E.
𝜎 = E𝜀

(2.4)

Modulus of elasticity is a number that measures an object or substance's resistance to
being deformed elastically (non-permanently) when a force is applied to it. The elastic
modulus of an object could be interpreted as the slope of its stress-strain curve in the
elastic deformation region [2].
An alternative form in which to present constituent equations is based on defining
potential energy of deformation as

𝑊=

1
𝐸𝜀 2
𝜎𝜀 =
2
2

(2.5)

(Lagrange principle). Taking the partial derivative of strain energy with respect to strain,
the constituent equation for stress-strain relationship is formed (Hooke’s Law).

𝜎=

𝜕𝑊
= 𝐸𝜀
𝜕𝜀

(2.6)

This approach will be used to build the constituent equations in nonlinear mechanics in
Chapter 4.
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2.3.2. 2D Linear Stress and Strain
A two-dimensional object stretched in x,y directions (shown in Figure 2.2) has an
initial length L10, L20, in the x,y directions, respectively, and a final length after force is
applied of L1, L2.

L20
L2

L10
L1

Figure 2.2. 2D object with an initial length of (L10,L20) and final length after a force is applied of (L1, L2).
The subscripts (1,2) are used to represent general notation, valid for Cartesian, cylindrical or spherical
coordinates [1].

The stretch ratios are defined as

𝜆1 =

𝐿1
𝐿2
, 𝜆2 =
𝐿10
𝐿20

(2.7)

where subscripts 1, 2 are in the x,y direction, respectively. Similar to stretch, the
components of strain are defined as the ratio of change in length to original length.

𝜀1 =

𝐿1 − 𝐿10 𝛥𝐿1
=
𝐿10
𝐿10

𝜀2 =

𝐿2 − 𝐿20 𝛥𝐿2
=
𝐿20
𝐿20

𝜀1 = 𝜆1 − 1, 𝜀2 = 𝜆2 − 1

(2.8)
(2.9)
(2.10)

Strain is also related to the stretch ratio minus one. Hooke’s Law generalized to its 2D
counterpart now relates stress by introducing Poisson’s coefficient.
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𝜀1 =

1
(𝜎 − 𝜈𝜎2 )
𝐸 1

𝜀2 =

1
(𝜎 − 𝜈𝜎1 )
𝐸 2

(2.12)

𝜎1 =

𝐸
(𝜀 + 𝜈𝜀2 )
1 − 𝜈2 1

(2.13)

𝜎2 =

𝐸
(𝜀 + 𝜈𝜀1 )
1 − 𝜈2 2

(2.14)

(2.11)

When a 2D material is stretched in one direction, it usually tends to compress in the
other direction perpendicular to the direction of extension. This phenomenon is called
the Poisson effect. Poisson's coefficient 𝜈 is a measure of this effect.
Extending Hooke’s law, it is then possible to define strain energy.

σ2

σ1

σ1

σ2

Figure 2.3. 2D strain energy under extension in both directions.

The alternative way to build 2D constituent equations is based on defining potential
energy of deformation in the 2D case as
1

𝐸

𝑊 = 2 (𝜎1 𝜀1 + 𝜎2 𝜀2 ) = 2(1−𝜈2 ) (𝜀12 + 2𝜈𝜀1 𝜀2 + 𝜀22 )

(2.15)

(Lagrange approach). By taking the partial derivative of strain energy with respect to
strain, the 2D form of Hooke’s Law results.
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𝜎1 =

𝜕𝑊
𝐸
=
(𝜀 + 𝜈𝜀2 )
𝜕𝜀1 (1 − 𝜈 2 ) 1

𝜎2 =

𝜕𝑊
𝐸
=
(𝜀 + 𝜈𝜀1 )
𝜕𝜀2 (1 − 𝜈 2 ) 2

(2.16)
(2.17)

2.3.3. Stress-Force Relationship in Linear Mechanics
To understand the stress-force relationship, consider a simple 3D object as shown
in Figure 2.4.

F2

F1

h0

F1

L20
L10
F2

Figure 2.4. Stress-force relationship on a simple 3D object, where F 1,F2 represent force in the x,y
direction, respectively. L10,L20 represent the initial unstressed length in the x,y direction, and h0 represents
the initial unstressed thickness.

𝜎1 =

𝐹1
𝐿20 ℎ0

(2.18)

𝜎2 =

𝐹2
𝐿10 ℎ0

(2.19)

Defining stress components in linear mechanics, the change of geometry during
deformation is neglected. In Figure 2.4, a 3D object is shown with a thin third dimension,
which is the thickness of the shell. Stresses in the direction of thickness are neglected,
but the change in thickness can be predicted from an incompressibility condition.
Stresses in one and two directions are statically determinate (i.e., can be
calculated explicitly based on statics). Because 𝜎3 is neglected, our physical shell model

42

is two-dimensional, although the third dimension is used to specify the thickness. The
information described in this section is used as the foundation to develop the second
and third models for pulse wave velocity prediction in nonlinear thin- and thick-walled
elastic arterial segments in Chapters 4 and 5.

2.3.4. 2D Linear Vessel
The stress-force relationship is now extended to gain understanding of a simple 2D
linear vessel wall [3,4].

p

r

p

p
σθ

σθ

Figure 2.5. 2D linear circumferential stress on a vessel in equilibrium. The lower right image highlights
the direction of the circumferential stress with the applied transmural pressure. The thickness (h) is a
constant in a linear model in which deformation is not taken into account.

Static equilibrium conditions, as shown in Figure 2.5, result in
2𝜎𝜃 ℎ = 𝑝2𝑟
𝜎𝜃 =

𝑝𝑟
ℎ

(2.20)
(2.21)

where σθ is circumferential stress. In addition to circumferential stress, a vessel under
pressure experiences axial or longitudinal stress (σz), calculated from static equilibrium
in the axial direction as shown in Figure 2.6.
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σz
p
σz

Figure 2.6. 2D linear axial stress on a vessel in equilibrium. The thickness (h) is a constant in a linear
model in which deformation is not taken into account.

𝜎𝑧 2𝜋𝑟ℎ = 𝜋𝑟 2 𝑝
𝜎𝑧 =

𝑝𝑟 𝜎𝜃
=
2ℎ
2

(2.22)
(2.23)

For both circumferential and axial stress, the effect of deformation is not required by the
linear model. The information described in this section is used as the foundation to
develop the first model for Pulse Wave Velocity Prediction and Compliance Assessment
in Linear Elastic Arterial Segments in Chapter 3.

2.3.5. Nonlinear Elasticity, Finite Deformation
In the linear case, deformation was not considered. However, the first step in
accounting for nonlinearity is to take the effect of deformation into account. Analyzing
uniform stretch for the block along the block sides L10 , L20 , h0 , the stretch ratio is now
defined as (L1 , L2 , ℎ - the block sides after deformation)

𝜆1 =

L1
L2
h
; 𝜆2 =
; 𝜆3 =
L10
L20
h0

(2.24)

for all three directions [1]. If the material is incompressible, then
𝐿1 𝐿2 h = 𝐿10 𝐿20 ℎ0 ;

𝜆1 𝜆2 𝜆3 = 1

(2.25)

which means that the initial volume of the arterial wall must be equal to the final volume.
It also sets the product of all stretch ratios equal to one. Figure 2.7 illustrates an
infinitesimally small object before and after deformation.
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dL 0

dL

dy

dY

dx
dX

Figure 2.7. Illustration of an infinitesimally small element before (left) and after (right) deformation.

Analyzing deformation for the non-uniform point-dependent stretch, L10 , L20 are
substituted with 𝑑𝑥, 𝑑𝑦, and 𝐿1, 𝐿2 𝑤𝑖𝑡ℎ 𝑑𝑋, 𝑑𝑌. As a result,

𝜆𝑥 =

𝑑𝑋
;
𝑑𝑥

𝜆𝑦 =

𝑑𝑌
𝑑𝑦

(2.26)

where capital (X,Y) are the Lagrangian coordinates associated with deformed particles,
and the lowercase coordinates (x,y) relate to the strain-free case. By using the
Pythagorean Theorem

𝑑𝐿0 = √𝑑𝑥 2 + 𝑑𝑦 2 ;

𝑑𝐿 = √𝑑𝑋 2 + 𝑑𝑌 2

(2.27)

dL0, dL can be calculated. The Green strain is defined as
𝑑𝐿2 − 𝑑𝐿20
(2.28)
2𝑑𝐿20
By combining equations (2.26), (2.27), and (2.28), in terms of dx,dy, equation (2.29)
𝐺=

results.
(𝜆2𝑥 − 1)𝑑𝑥 2 + (𝜆2𝑦 − 1)𝑑𝑦 2
𝜆2𝑥 𝑑𝑥 2 + 𝜆2𝑦 𝑑𝑦 2 − (𝑑𝑥 2 + 𝑑𝑦 2 )
(2.29)
𝐺=
;
2(𝑑𝑥 2 + 𝑑𝑦 2 )
2(𝑑𝑥 2 + 𝑑𝑦 2 )
Setting deformation in the y-direction to zero (dy=0) results in a one-dimensional xcomponent of Green strain.
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𝜆2𝑥 − 1
(2.30)
𝐺𝑥 =
;
2
Setting deformation in the x-direction to zero (dx=0) results in a one-dimensional ycomponent of Green strain.
𝜆2𝑦 − 1
𝐺𝑦 =
;
2
For small deformation, where (∆𝐿1 ≪ 𝐿10 )

𝜆𝑥 =

𝐿1
𝐿10 + 𝛥𝐿1
=
; (∆𝐿1 ≪ 𝐿10 )
𝐿10
𝐿10

1 𝐿10 + ∆𝐿1 2
1 𝐿210 + 2𝐿10 𝛥𝐿1 + 𝛥𝐿21 − 𝐿210
𝐺𝑥 = ((
) − 1) = (
)
2
𝐿10
2
𝐿210
∆𝐿1
∆𝐿2
𝐺𝑥 ≅
= 𝜀𝑥 ; 𝐺𝑦 ≅
= 𝜀𝑦
𝐿10
𝐿20

(2.31)

(2.32)
(2.33)
(2.34)

Green strain components are identical to deformation introduced in a linear theory of
elasticity.
Cauchy-Euler stress takes into account the change in geometry during
deformation, defined as the ratio of force to the real area.

𝜎1 =

𝐹1
;
𝐿2 ℎ

𝜎2 =

𝐹2
𝐿1 ℎ

(2.35)

Piola-Lagrange stress uses the initial state of the area.

𝑇1 =

𝐹1
;
𝐿20 ℎ0

𝑇2 =

𝐹2
𝐿10 ℎ0

(2.36)

The two different types of stress (35,36) are related by
𝜎1
𝐿20
1
=
=
= 𝜆1
𝑇1 𝐿20 ℎ0 𝜆2 𝜆3

(2.37)

𝜎1 = 𝑇1 𝜆1 ; 𝜎2 = 𝑇2 𝜆2

(2.38)

the stretch ratio.
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Kirchhoff’s stress components (𝑆1 , 𝑆2 ) are related to the corresponding Cauchy and
Lagrange components as the following:

𝑆1 =

𝜎1 𝑇1
= ;
𝜆12 𝜆1

𝑆2 =

𝜎2 𝑇2
=
𝜆22 𝜆2

(2.39)

Kirchhoff’s stress components can be expressed as a partial derivative of strain energy
by relating Green’s strain components

𝑆1 =

𝜕𝑊
;
𝜕𝐸1

𝑆2 =

𝜕𝑊
𝜕𝐸2

(2.40)

The information described in this section is used as the foundation to develop the
second and third models for pulse wave velocity prediction in nonlinear thin- and thickwalled elastic arterial segments in Chapters 4 and 5.
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2.4.

Conclusion

In this chapter, 1D and 2D stress strain relationships were reviewed. The basic
stress-force relationships were covered without accounting for deformation.
Incorporating this information, the 2D linear vessel was reviewed. Special attention was
given to define both the longitudinal and circumferential stress. The effects of
nonlinearity were then considered. Considering the effect of deformation, Cauchy-Euler,
Piola-Lagrange, and Kirchoff stresses were defined and related. The foundation of
nonlinear mechanics of material presented in this chapter will be used for the models
that are described in Chapters 3-5.
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Chapter 3: Pulse Wave Velocity Prediction
and Compliance Assessment in Linear Elastic
Arterial Segments
…when you can measure what you are speaking about, and express it in numbers, you know something
about it; but when you cannot measure it, when you cannot express it in numbers, your knowledge is of a
meagre and unsatisfactory kind; it may be the beginning of knowledge, but you have scarcely, in your
thoughts, advanced to the state of Science whatever the matter may be. - Lord Kelvin

3.1.

Abstract

Pressure wave velocity (PWV) is commonly used as a clinical marker of vascular
elasticity [1-9]. Recent studies have increased clinical interest in also analyzing the
impact of heart rate (HR), blood pressure, and left ventricular ejection time (LVET) on
PWV. In this chapter, the focus is on the development of a theoretical one-dimensional
model and validation via direct measurement of the impact of ejection time and peak
pressure on PWV using an in vitro hemodynamic simulator. A simple nonlinear traveling
wave model was developed for a compliant thin-walled elastic tube filled with an
incompressible fluid. This model accounts for the convective fluid phenomena, elastic
vessel deformation, radial motion, and inertia of the wall. An exact analytical solution for
PWV is presented that incorporates peak pressure, ejection time, ejection volume, and
modulus of elasticity. To assess arterial compliance, the solution is introduced in an
alternative form, explicitly determining compliance of the wall as a function of the other
variables. The model predicts PWV in good agreement with the measured values, with
a maximum difference of 3.0%. The results indicate an inverse quadratic relationship
(R2 = .99) between ejection time and PWV, with ejection time dominating the PWV
shifts (12%) over those observed with changes in peak pressure (2%). Our modeling
and validation results both explain and support the emerging evidence that, in both
clinical practice and clinical research, variables related to cardiac systolic function
should be regularly taken into account when interpreting arterial function indices,
namely PWV.
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3.2.
A
c
𝑐𝑀𝐾

E
F
h 0, h
L0
L
ΔL
ν
p
ρ
ρw
PTT
PWV
r
u
η
Subscripts
(t,z)
Superscripts

‘

Nomenclature
Cross-sectional area (m2)
Velocity of a traveling wave (m/s)
Moens-Korteweg speed of propagation (m/s)
Modulus of elasticity (Pa)
Force (N)
Thickness of the wall in zero-stress and deformable conditions, respectively (m)
1D initial length (m)
1D final length (m)
Elongation (m)
Poisson’s coefficient
Transmural pressure (Pa)
Density of an incompressible fluid (kg/m3)
Density of the cylindrical wall (kg/m3)
Pulse transit time (s)
Pressure wave velocity (m/s)
Radius (m)
Axial flow velocity (m/s)
Circumferential wall strain
Derivatives by time and axial coordinates
Derivative
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3.3.

Introduction

The pulse wave, generated by left ventricular ejection, propagates at a velocity
that has been identified as an important marker of atherosclerosis and cardiovascular
risk [1-9]. Increased pulse wave velocity indicates an increased risk of stroke and
coronary heart disease [1]. This velocity is considered a surrogate marker for arterial
compliance [2], is highly reproducible [2], and is widely used to assess the elastic
properties of the arterial tree [3]. Research shows that aortic compliance measurement
using pulse wave velocity could allow for early identification of patients at risk for
cardiovascular disease [1,3,7]. The ability to identify these patients would lead to better
risk stratification and earlier, more cost-effective preventative therapy [4]. Several
studies have shown the influence of blood pressure [1,11-13] and LVET [3, 5] on pulse
wave velocity.
Over the past several decades, there has been ongoing research focused on
improving the theoretical prediction of PWV. The clinical relationship between PWV and
arterial stiffness is often based on classic linear models [8,15] or on the combination of
the linear models and measured results with an incorporated correction factor [16-18].
Whereas linear models predict PWV as a function of only geometric and physical
properties of the fluid and the wall, there is strong evidence that PWV is also correlated
with pressure [11-13] and ejection time [3, 5]
While both pressure and LVET are shown clinically to affect pulse wave velocity,
a predictive model that provides mechanistic insight and incorporates peak pressure,
ejection time, ejection volume, and modulus of elasticity has yet to be developed. The
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aim of this study is to develop and validate a model to provide this missing insight. The
approach used is based on a one-dimensional nonlinear model for pressure wave
propagation in a compliant tube with a linear elastic wall filled with an incompressible
fluid. The model incorporates the classical solitary wave-based solution, connecting
speed of propagation to the ejection time, ejection volume, and peak pressure. It
accounts for nonlinear wave propagation effects, elastic deformable vessels, and the
inertia of the distensible vessel walls. The model is validated using a physiologically
based electromechanical hemodynamic simulator.
To assess the impact of arterial stiffness, the theoretical solution is introduced in
an alternative form, to enable explicit determination of the vascular wall’s elasticity (or
compliance) as a function of PWV, peak pressure, ejection volume, and ejection time.
This solution is a natural generalization of Bramwell–Hill theory [6] that directly relates
compliance to PWV only, independent of the other factors.
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3.4.

Theory

3.4.1. Nonlinear Model for Pressure Wave Propagation
A nonlinear one-dimensional model for blood pressure wave propagation in
compliant arteries was created. As shown Figure 3.1, this model assumes a compliant
tube with a linear elastic wall filled with an incompressible inviscid fluid.

Figure 3.1. Longitudinal cross section of the arterial wall being modelled in the r, z plane, where r, z are
the radial and axial coordinates, respectively. The cylinder is represented at two specific times in the
cardiac cycle: diastolic pressure (shown at foot red circle, lowest pressure) and systolic pressure (shown
by blue square, peak pressure). The wall thickness h, initial inner diameter 𝑟0 , and wall displacement ∆𝑟
are exaggerated for the purpose of illustration.

At each spatial location z and at each time t, the average cross-sectional axial
flow velocity u=u(z,t), static pressure p=p(z,t), cross-sectional area A=A(z,t), and
membrane circumferential strain (ratio of the normal displacement to the radius) η=η(z,t)
are calculated. Application of the laws of conservation of mass and conservation of
momentum results in the following set of 1D equations [20,21], correspondingly:
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𝐴𝑡 + (𝑢𝐴)𝑧 = 0
𝑢𝑡 + (

𝑢2 𝑝
+ ) =0
2 𝜌 𝑧

(3.1)
(3.2)

where: ρ is the density of the fluid, assumed to be constant. Subscripts indicate
partial derivative by the corresponding space and time variables (z, t), respectively.
Equilibrium conditions maintain the following relationship between pressure,
circumferential stress, and inertia of the moving wall:

𝑝=

𝐸̅ ℎ
𝜂 + 𝜌𝑤 ℎ𝑟0 𝜂𝑡𝑡
𝑟0

(3.3)

where: 𝐸 is the elastic modulus for the wall, ν is Poisson’s coefficient; and 𝐸̅ =
𝐸/(1 − 𝜈 2 ); h is the constant thickness of the wall, r0 is the cross-sectional radius of the
unstressed cylindrical vessel (𝑝 = 0), ρw is the density of the cylindrical wall, and η is
circumferential wall strain. Noting that 𝐴 = 𝜋𝑟02 (1 + 𝜂)2 , the total system of equations
can be presented in the following non-conservative form:
1+𝜂
𝑢𝑧 = 0
2
1
𝑢𝑡 + 𝑢𝑢𝑧 + 𝑝𝑧 = 0
𝜌
𝐸̅ ℎ
𝑝=
𝜂 + 𝜌𝑤 ℎ𝑟0 𝜂𝑡𝑡
𝑟0

𝜂𝑡 + 𝑢𝜂𝑧 +

(3.4)
(3.5)
(3.6)

Following [22], we are looking for the solitary traveling wave solution in a form
𝜂(𝑧, 𝑡) = 𝜂(𝑍), 𝑢(𝑧, 𝑡) = 𝑢(𝑍), where 𝑍 = 𝑧 − 𝑐𝑡 and c represents the velocity of the
traveling wave. The functions 𝜂(𝑍), 𝑢(𝑍), 𝑝(𝑍) are assumed to be smooth, and
decaying monotonically as 𝑍 → ±∞.
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Substituting 𝜂(𝑍), 𝑢(𝑍) into equations (3.4-3.6), we obtain the following system of
ordinary differential equations where prime indicates the derivative with respect to Z:
1
(−𝑐 + 𝑢)𝜂′ + (𝜂 + 𝑟0 )𝑢′ = 0
2
−𝑐𝑢′ + 𝑢𝑢′ +

𝐸ℎ ′ 𝜌𝑤 ℎ 2 ′′′
𝜂 +
𝑐 𝜂 =0
𝜌
𝜌𝑟02

(3.7)
(3.8)

By neglecting the nonlinear terms in equations (3.7) and (3.8) and the wall inertia terms
in (3.8), the linearized hyperbolic system of equations can be presented as:
1
−𝑐𝜂′ + 𝑢′ = 0
2

(3.9)

𝐸ℎ ′
𝜂 − 𝑐𝑢′ = 0
𝜌𝑟0

(3.10)

−𝑐
A non-trivial solution exists only if ‖ 𝐸̅ℎ
𝑟0

1
2

−𝑐

‖ is presented in matrix form, where

𝐸ℎ
(3.11)
𝑐 = 𝑐𝑀𝐾 = √
2𝑟0 𝜌
is the Moens-Korteweg speed of propagation, which is a function of the mechanical
properties of the system only. For the general case, the total nonlinear dispersive wave
model in equations (3.7) and (3.8) must be considered. Separating variables in equation
(3.7), 2𝜂′ ⁄(1 + 𝜂) = 𝑢′ ⁄(𝑐 − 𝑢), integrating, and noting 𝑢(𝜂 = 0) = 𝑢0 which represents
the average flow velocity, the following relationship can be obtained:

𝑢=𝑐−

𝑐 − 𝑢0
(1 + 𝜂)2

(3.12)

Integrating equation (3.8) results in
𝑢2 𝑢02
𝐸ℎ
𝜌𝑤 ℎ𝑟0 2 ′′
)
−𝑐(𝑢 − 𝑢0 + ( − ) +
𝜂+
𝑐 𝜂 =0
2
2
𝜌𝑟0
𝜌

(3.13)
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A nonlinear momentum equation is obtained by multiplying equation (3.13) by 𝑑𝜂 and
integrating to yield:
𝜂

1 𝜂 2
𝐸ℎ 2 𝜌𝑤 ℎ𝑟0 2 ′ 2
−𝑐 ∫(𝑢 − 𝑢0 )𝑑𝜂 + ∫ (𝑢 − 𝑢02 )𝑑𝜂 +
𝜂 +
𝑐 (𝜂 ) = 0
2 0
2𝜌𝑟0
2𝜌

(3.14)

0

Equation (3.14) can be reduced to an algebraic form by analysis of the peak value of
the wave profile, 𝜂′ = 0. Calculating integrals of equation (3.14) based on equation
(3.12), and setting equation (3.14) at peak pressure, one can reduce the momentum
equation to the following form:

𝑃𝑊𝑉 = 𝑐 = 𝑢0 ± 𝑐𝑀𝐾
𝜂

1

𝐴𝜂
√Γ(𝐴𝜂 )

(3.15)

1

where 𝛤(𝜂) = 2 − 6 (1 − (1+𝜂)3 ), and 𝐴𝜂 = 𝑚𝑎𝑥(𝜂(𝑍)) is the peak circumferential strain.
Equation (3.15) presents PWV of the forward and backward solitary wave propagation.
Based on asymptotic expansion

𝐴𝜂
√𝛤(𝐴𝜂 )

5

= 1 + 6 𝐴𝜂 + 𝑂(𝐴2𝜂 ), where O is the order of

accuracy, equation (3.15) reduces to a simplified form using the second order of
accuracy:
5
𝑐 = 𝑢0 + 𝑐𝑀𝐾 (1 + 𝐴𝜂 )
6

(3.16)

indicating a correction to the classical Moens-Korteweg model, introduced by the
present theory. The peak of flow velocity 𝐴𝑢 , volume flow rate 𝐴𝑄 , and pressure 𝐴𝑝 are
dependent on c as follows from equations (3.6), (3.12), (3.13), and (3.15):

𝐴𝑢 = 𝑐 −

𝑐 − 𝑢0
(1 + 𝐴𝜂 )2

(3.17)

𝐴𝑄 ⁄𝜋𝑟02 = 𝐴𝑢 × (1 + 𝐴𝜂 )2

(3.18)

𝐴2𝑢 𝑢02
𝐴𝑝 ⁄𝜌 = 𝑐(𝐴𝑢 − 𝑢0 ) − ( − )
2
2

(3.19)
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According to the traveling wave model, pressure, flow, and wall displacement
propagate with the same speed of propagation, c. The linear model predicts that all
waves travel with the Moens-Korteweg speed (𝑐𝑀𝐾 ), but accounting for nonlinearities
predicts a speed of propagation that exceeds 𝑐𝑀𝐾 . As expected for soliton nonlinear
waves, the higher peak pressure wave travels with a higher speed [7]. This trend is
similar to the results derived differently in [7], and it is consistent with the clinical data
obtained in [8]. As ejection time decreases, the average flow velocity u0 increases,
thereby increasing PWV as seen in equation (3.16).

3.4.2. Assessment of Arterial Compliance
Quantification of pulse wave velocity is typically considered the ‘‘gold standard’’
method to assess arterial compliance [9]. The nonlinear model can be extended to
estimate aortic compliance as a function of PWV, peak pressure, ejection time, and
ejection volume. The classic definition of compliance (C) is C = ΔV/ΔP, where (ΔV) is
the change in arterial blood volume for the defined arterial segment and (ΔP) is the
associated change in arterial blood pressure. Using the pressure/displacement and
volume/displacement relationships (𝐴𝑠 is the surface area, and V is the internal volume
of the arterial segment):

∆𝑃 =

𝐸̅ ℎ
2
𝜂 = 2𝜌𝜂𝑐𝑀𝐾
𝑟0

∆𝑉 = 𝐴𝑠 𝑟0 𝜂 = 2𝑉𝜂

(3.20)
(3.21)

the Bramwell-Hill compliance (CBH) can be determined as:
∆𝑉
𝑉
= 𝐶𝐵𝐻 = 2
∆𝑃
𝜌𝑐𝑀𝐾

(3.22)
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In practice, the volumetric compliance is calculated based on the measured pressure
wave velocity [9]:

𝐶=

𝑉
𝜌𝑃𝑊𝑉 2

(3.23)

To estimate the error introduced by equation (3.23), we transform it using equation
(3.15), and we form the expression that explicitly estimates its proximity to the exact
value:
𝐶=

𝑉
𝑢0

2
𝜌𝑐𝑀𝐾
(𝑐

𝑀𝐾

+

𝐴𝜂

5
𝑢0
𝑢0 2
= 𝐶𝐵𝐻 [1 − 𝐴𝜂 − 2
+ 𝑂(𝐴2𝜂 ) + 𝑂(
) ]
3
𝑐𝑀𝐾
𝑐𝑀𝐾
)2

(3.24)

√Γ(𝐴𝜂 )

Neglecting the quadratic terms, we introduce a corrected coefficient for elastance,
defined as a ratio of compliance (C) to the Bramwell-Hill compliance (CBH)

𝐶 ⁄𝐶𝐵𝐻 = (1 −

5
𝑢0
𝐴𝜂 − 2
)
3
𝑐𝑀𝐾

(3.25)

This coefficient could be useful to decrease the error associated with equation (3.23).

60

3.5.

Materials and Methods

3.5.1. Hemodynamic Simulator
A physiologically based electromechanical cardiovascular simulator was
developed, which is a modified version of that described in [10]. The simulator is
capable of producing arterial hemodynamic flows and pressures associated with the
circulatory system. As shown in Figure 3.2, a linear actuator (THK linear actuator, VLAST-60-12-0250), driven by a servomotor (Yaskawa Sigma-V) is used to produce
repeatable fluid flow by displacement of a given fluid volume creating a repeatable
pressure in the compression chamber. LabVIEW is used to control the servomotor for
accurate control of the fluid ejection time. LabVIEW was also used to record the
measurements from the pressure and flow sensors used in the simulator.
The pressure sensors (P1, P2, venous pressure) and flow sensors (F1, F2) are
located as shown in Figure 3.2. Sensors are placed at a location representing the
proximal aorta (P1, F1) and distal aorta (P2, F2). The venous pressure sensor is located
distal to the resistive element. Systemic vascular resistance (SVR) is controlled by the
Windkessel resistive elements (E1, E2). Mean aortic flow was determined from
measurements obtained using the distal flow sensor (F2). The mean was calculated
in MATLAB for each sixty-second dataset. SVR and ejection volume were calculated as
described in [11], 𝑆𝑉𝑅 = (𝑀𝐴𝑃𝑎 − 𝑀𝐴𝑃𝑣 )⁄𝐹𝑎 , where 𝑀𝐴𝑃𝑎 is mean aortic pressure; 𝑀𝐴𝑃𝑣
is mean venous pressure; 𝐹𝑎 is mean aortic flow; and the units of SVR, mean aortic
flow, and aortic and venous MAP are 𝑚𝑚𝐻𝑔 ∙ 𝑚𝑖𝑛⁄𝐿, 𝐿⁄𝑚𝑖𝑛, and mmHg, respectively.
The experimental pulse rate was kept at a constant 60 beats per minute (BPM) with
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ejection volume (EV) calculated as EV = 𝐹𝑎 ⁄PR , where PR is pulse rate and the units of
ejection volume, mean aortic flow, and pulse rate are L, 𝐿⁄𝑚𝑖𝑛, and 𝑏𝑒𝑎𝑡𝑠⁄𝑚𝑖𝑛.
The simulator contains both an arterial afterload and a venous preload
compliance chamber with air volumes of 0.72 L and 3.83 L, respectively. A
sphygmomanometer bulb controls chamber pressures with manual pressure readout via
an associated mechanical pressure gauge. Prior to starting an experiment, both
chambers were pressurized to ~5 mmHg. This resulted in a dynamic MAP of 85 mmHg
during experiments.

Figure 3.2. Illustration of the cardiovascular hemodynamic simulator with a total volume of 5.75 L. P1, P2
are the proximal and distal aortic pressure sensors. F1, F2 are the proximal and distal aortic flow sensors.
The Windkessel resistive elements are used to model SVR as in [12]. An adjustable-rate servomotor was
used to control ejection time. In the right part of the figure is an expanded view showing the addition of
the high-speed camera setup used to measure wall displacement.
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3.5.1.1.

Pressure and Flow Sensors

Pressure was measured using factory calibrated (±1 mmHg), catheter-based,
solid-state pressure transducers (Millar Instruments, Mikro-Cath 3.5F pressure catheter,
sterile, disposable, 120 cm). Flow was measured using precision tubing transit time flow
sensors (Transonic Systems Inc., ME-PXL-Series) calibrated to achieve a flow
measurement accuracy of ±2%. Transonic Systems, Inc. calibrated the flow sensors
with the tubing used for all experiments.
3.5.1.2.

Aortic Tubing

Tubing was selected with compliance values to approximate the elasticity of the
aorta. Papageorgiou and Jones [13] studied Tygon, Silastic, PVC, and Latex tubing and
determined that Latex tubing was most suitable for arterial simulation because the
incremental modulus of elasticity was close to that of major arteries. In this study
(McMaster-CARR, 5234K631), (ID = 19.05 mm, OD = 22.22 mm, wall thickness =
1.59 mm), Latex rubber was selected. Static pressurization tests were performed on the
selected tubing to empirically measure the tubing compliance. The tubing was
pressurized in 12 equal steps [0-200 mmHg] while monitoring the internal pressure with
a catheter pressure transducer (Validyne P855). The outer diameter of the compliant
tubing was imaged using a digital camera (IDT Motion Pro X3, 1280x1024 pixels, 500
frames per second). The images were post-processed to determine the outer diameter
of the tubing at each pressure level. There was an approximately linear (R2 = 0.99)
relationship between the expansion of the compliant tubing and the increasing static
pressures within the tested operating pressure range, with a slope of 0.15 mm/mmHg
and an intercept of 22.22 mm. The linear relationship indicates that the tubing remains
within the linear elastic range, which is consistent with the results obtained by [26,27].
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Based on the referenced studies and the measured results, this tubing was then used
for all experiments.
3.5.1.3.

Systemic Vascular Resistance

A physical Windkessel resistance was constructed to serve as a laminar flow
control element and was attached 20 cm distal from sensors (P2, F2), to provide
realistic outflow impedances, as shown in Figure 3.2. The construction methods used in
this work were adapted from Taylor and Kung [12]. The resistance modules were
connected to PVC tubing at each end. To avoid turbulence and maintain laminar flow,
care was taken to minimize abrupt diameter changes at the connection junction.

3.5.2. Hemodynamic Simulation Experiment
Hemodynamic parameters were directly measured and PWV was determined
while varying ejection time, at a fixed ejection volume, SVR, mean aortic flow, and HR
of 60 BPM for a duration of 60 seconds. All signals were low pass filtered (Butterworth
filter, eight pole zero phase) with a corner frequency set at 20 Hz [14]. Automated
MATLAB algorithms were used to extract the foot-to-foot delta time for the proximal and
distal pressure. The percent height method was implemented to find the diastolic foot
[15, 16]. The associated PWV was calculated by dividing the distance between the
sensors, shown in Figure 3.2, by the extracted foot-to-foot delta time. Extracted results
were averaged, and the standard deviation was calculated across a 60-second interval
for each ejection time. GraphPad Prism 5 statistical analysis software was used to
determine the correlation between PWV and ejection time. Simple Pearson linear
regression analysis was applied to detect and describe the strength and sign of
correlation of PWV with respect to LVET.
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3.6.

Results and Discussion

3.6.1. Comparison of the Model to the Hemodynamic Simulator Data
Figure 3.3 compares theoretical simulated prediction of PWV as a function of a
average flow velocity and peak pressure to the measured values using the
hemodynamic simulator.

Figure 3.3. Dashed lines present prediction from the theoretical model for five different average flow
velocities 𝑢0 and peak pressure controlled by ejection time at a fixed SVR. Data points allow comparison
of predicted (circle) and measured (square) PWV. To move left to right along arrow (A), peak pressure
increases while average flow velocity remains constant. Movement vertically along arrow (B) occurs if
average flow velocity increases while peak pressure remains constant. Finally, to move upward along the
quadratic arrow as in the measured data points (C), both peak pressure and average flow velocity
increase as demonstrated by data obtained from the set of experiments and those calculated from the 1D
nonlinear traveling wave model.

Dashed lines present predictions based on equation (3.16) for the five different average
flow velocities 𝑢0 and peak pressure controlled by ejection time at a fixed SVR. The
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maximum difference between theoretically simulated and measured results is 3.0%.
Flow velocity and peak pressure changes controlled by ejection time result in the
quadratic PWV curve observed in Figure 3.3 (arrow C).
The coefficient of determination and p-value were calculated to be R2 = 0.99 and
p = 0.0001, respectively, demonstrating a strong correlation between PWV and ejection
time. PWV is substantially affected by average flow velocity (~10%) and peak pressure
(~2%) changes controlled by ejection time (12% over the analyzed range, arrow C), as
seen in the measured and simulated results. However, for a fixed ejection time,
changes in PWV due to shifts in peak pressure alone are relatively small (2%).
Table 3.1 lists the calculated values of ejection volume and SVR with respect to
ejection time. As shown in the table, ejection volume, SVR, MAP, and aortic flow rate do
not change with varying ejection time in the hemodynamic simulator. The small changes
in calculated ejection volume were caused by small mean aortic flow variations.
Table 3.1. Hemodynamic measured values are maintained within the clinical range.
Ejection
Time
[ms]

Ejection
Volume*
[ml]

SVR*
[mmHg ·min/L]

SBP/DBP/MAP
[mmHg]

Venous
MAP
[mmHg]

Mean Aortic
Flow
[LPM]

434

66.1

15.4

117/60/82

22

3.9

382

67.8

15.7

131/56/86

23

4.0

326

66.1

15.9

136/53/85

23

3.9

297

66.9

15.4

139/51/85

24

3.9

252

66.8

15.5

142/49/85

24

3.9

*Calculated Value
Values maintained within a clinical range using the cardiovascular hemodynamic simulator. Changes in
ejection volume were caused by aortic flow variation. Clinical range for LVET (150-450) [17]; Ejection
Volume (55-100 ml) [17]; SVR (9-20 mmHg ·min/L) [18]; SBP (90-180) [17]; DBP (40-110) [17]; Mean
Aortic Flow (4-7) [17]. Values are expressed as means over each 60-second interval. For all measures of
ejection time, pressure, and flow, the standard deviations were below 1.3 ms, 0.1 mmHg, 0.02 LPM
respectively.
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For a constant MAP, the associated PWV varied by up to 12% (182 ms) over the
range of measured ejection time (252-434 ms). The mean and standard deviation for
both MAP and SVR are 84.1, ±1.4 mmHg and 15.4, ±0.25 𝑚𝑚𝐻𝑔 ∙ 𝑚𝑖𝑛⁄𝐿 respectively,
which confirms that both remained nearly constant across the range of ejection times
tested. The MAP remained approximately constant. However, the SBP increased by 25
mmHg, and the DBP decreased by approximately 11 mmHg as a function of LVET
decreasing.
As can be seen across the range of ejection times in Table 3.1, the associated
DBP changed from approximately 60-49 mmHg, for a nearly constant SVR and MAP. In
our experiment, no adjustments were made across the five steps of decreasing ejection
time. Since the ejection time decreased while heart rate and ejection volume remained
constant, the time spent in diastole increased and thus resulted in a decreasing DBP.
The opposite effect is observed for SBP, which increased from 117-142mmHg as
ejection time decreased. The observed changes for both SBP and DBP are consistent
with those observed clinically with changes in ejection time [17], but are on the low side
of clinical relevance. Increases in flow rate would have further increased the effect on
PWV, as can be seen by equation (3.16).
The contour plot Figure 3.4(a) enables visualization of the effect of ejection time
and peak pressure on PWV. Ejection time decreasing at a fixed peak pressure affects
PWV to a greater extent than increases to peak pressure at a fixed ejection time, as
seen in Figure 3.3 and Figure 3.4. Referencing equation (3.16) and Figure 3.4(b) gives
insight into the effects of average flow velocity (~10%) and wall strain (~2%) on PWV.
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(a)

(b)

Figure 3.4. (a) PWV (m/s) contour plot that illustrates a greater change in PWV caused by ejection time
when compared with a change in peak pressure alone. The simplified linear result (𝑐𝑀𝐾 = ~9.8 m/s)
occurs as peak pressure approaches zero and ejection time approaches infinity. (b) PWV (m/s) contour
plot that illustrates the effect of both average flow velocity and wall strain as seen in equation (3.16). In
each plot, the vertical gray rectangle encloses the range of our measured data using the hemodynamic
simulator.

3.6.2. Mechanisms Causing the Association between PWV and LVET
The main novel contribution of the present study is the creation and validation of
an analytical model that explains the mechanism for the observed inverse association
between PWV and LVET. We used the nonlinear traveling wave model to investigate
mechanisms underlying the effects of pressure, ejection time, ejection volume,
geometric properties, and physical properties on PWV. The model is based on mass
and momentum conservation applied to the incompressible fluid propagating in a thinwalled compliant elastic tube. The presented nonlinear traveling wave model accounts
for the convective fluid phenomena, elastic vessel deformation, and inertia of the wall.
Data analysis results in an analytical expression, generalizing the classical MoensKorteweg speed of propagation to include the effect of peak pressure and ejection time
on PWV, as shown in equation (3.16).
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For very small changes in transmural pressure approaching ~0 mmHg, results
simplify to those obtained from the linear Moens-Korteweg model (cMK), as shown in
equation (3.11). However, for clinically relevant changes in transmural pressure
(SBP/DBP), our nonlinear model shows that as ejection time decreases, the average
flow velocity (u0), pressure (p), and wall strain (η) increase. Since PWV is a function of
the average flow velocity (u0) and the Moens-Korteweg velocity cMK scaled by the wall
strain as seen in equation (3.16), this results in an increase in PWV with reductions in
ejection time. Accounting for these nonlinearities predicts a speed of propagation that
exceeds cMK by 12% across the physiological range of transmural pressures and
ejection times examined in this work.
Physiologic states involve a complex interaction of multiple variables. The three
arrows in Figure 3.3 provide insight into these complex relationships. It is possible to
suggest clinical scenarios for the changes in PWV as shown in Figure 3.3. In moving left
to right along arrow (A), SVR changes while ejection time and stroke volume remain
constant, which can occur in hypertension [19]. During digestion, SVR decreases while
ejection volume increases [20], which will approximately follow arrow (B). Finally, in
moving along the quadratic arrow, as in our measured data points (C), ejection time
changes while stroke volume and SVR remain constant (this work), which can occur
during sleep [21].
The presented model and validation results both show an inverse quadratic
relationship between LVET and PWV that has been previously observed. Nurnberger et
al. [11] used myocardial stimulation to modulate ejection time and measure the
associated change in PWV that was found to correlate only with LVET (R2 = 0.52,
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p = 0.0325). In their study, a change in ejection time of ~40 ms caused a change in
PWV of ~1 m/s. Salvi et al. [14] performed a large population study to explore the link
between PWV and LVET. An inverse association was found between PWV and LVET at
all ages (<R2 = 0.43; p < 0.001). In both studies, it was not possible in vivo to control
LVET, SVR, and ejection volume, which likely decreased their observed correlation. We
recognize that our PWV was higher than those measured by Nurnberger. This was
likely caused by the higher modulus of elasticity of our tube when compared with that of
the healthy human aorta. However, our PWV was within the range of that measured in
an older-age population (>45 years of age) [5]. A lower modulus of elasticity would have
shifted cMK as shown in equation (3.11) and resulted in a lower PWV range, as shown
by equation (3.16).
An analytical solution was obtained in equation (3.16) that presents PWV in an
explicit form as a nonlinear function of the average flow velocity and the peak pressure
of the wave. Measured and theoretical values agreed to within 3%. Our model showed
the impact of the nonlinear effects of ejection time on PWV, which varied by up to 12%
over a clinical range of ejection time. PWV is substantially affected by average flow
velocity (~10%) and peak pressure (~2%) changes controlled within the physiological
range of LVET, and it is affected to a lesser extent by peak pressure changes alone
(~2%). These results are consistent with the conclusions supported by clinical studies of
Nurenberg et al. [3] and Salvi et al. [5], regarding LVET as an important predictor of
PWV.
We recognize that further work is necessary to incorporate the viscoelastic model
of an arterial wall and to solve for PWV at both SBP and DBP. In addition, we recognize
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that a set of clinical studies is required to validate this model. To investigate whether our
model could be extended for use in vivo, we extracted the intra-arterial data from Chen
et al. [22] and compared it against our model. Since our model was derived for a linear
elastic tube, we use the nonlinear elastic modulus approximation presented by Hughes
et al. [23] (𝐸 = 𝐸0 𝑒 𝑎𝑃 , where E is the elastic modulus adjusted for pressure, E0 is the
elastic modulus at zero pressure, ‘a’ is the per-patient constant, and P is pressure) to
calculate a pressure-dependent cMK for equation (3.16).
To compare the model to the extracted clinical data (19-year-old female, Figure
3.5 (a); and 58-year-old female, Figure 3.5 (b)), cMK was estimated from the zero
crossing of an extension of the fitting curve presented in [34]; cMK was ~4.8 m/s and
~5.2 m/s for Figure 3.5 (a) and (b), respectively.

Figure 3.5. Extracted clinical data (squares) [34] of PWV vs intra-arterial blood pressure for a 19-year-old
female (a) and a 58-year-old female (b) obtained during surgery. Sweeping the model across the range of
possible ejection times and volumes (Table 3.1 footnote) results in the gray region. The solid line
represents the best-fit pressure PWV curve for each patient.

The radii for the 19-year-old and 58-year-old patient were selected based on age as
12.2 mm and 15 mm, respectively [8]. The wall thickness and blood density were kept
constant at 2.0 mm and 1025 kg/m3, respectively [8]. Using these values, we calculated
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the resulting E0 using equation (3.11). The per-patient constant ‘a’ (left to right a=0.01,
0.009 respectively) was adjusted to closely fit the individual’s PWV versus pressure
response, which is likely dominated by the dynamic elasticity of the aorta. In both cases,
the altered variables were maintained within the clinical range [17,18]. Since ejection
volume and time were not measured in the referenced study, the PWV versus pressure
relationship was estimated based on the ranges identified in the footnote of Table 3.1.
Differences in flow velocity (as determined from ejection time and volume) potentially
account for the measured scatter in the PWV versus pressure data points. The model
demonstrates the correct curvature, and the expected range (shown in gray) based on
flow velocity encompasses most of the measured data points. Data points outside of the
expected range could be due to surgically induced changes in ejection time and volume
beyond the range assumed for healthy individuals.
By adjusting the per-patient constant ‘a’, the model compares closely with the
extracted intra-arterial data, as seen in Figure 3.5. Using the best-fit line to the
measured data over the range of ejection times and volumes, we calculated an R2 value
between our model and the extracted data Figure 3.5 (a) and (b) of 0.87 and 0.85,
respectively. In addition, we generated a histogram and Gaussian fit to the residuals.
For both datasets, the residuals fit a Gaussian distribution. This indicates that the delta
from the model is likely due to random error, with calculated variance in Figure 3.5 (a)
and (b) of +/-1.04 and +/-0.90, respectively.
The finding of a relationship between LVET and PWV may be of clinical
importance [3]. Results from Nurenberg et al. [3], Salvi et al. [5], and this study indicate
that LVET affects PWV. Large studies of PWV have shown an intra-individual variability

72

of approximately 10% [1]. Correcting for LVET may allow for a decrease in the
measured intra-individual variability and more accurate comparisons between studies.
To correct for ejection time, both average flow velocity and wall strain need to be
measured and applied to equation (3.16). Average flow velocity can be measured using
Doppler ultrasound, and circumferential aortic wall strain can be measured using twodimensional ultrasound. We recognize that the circumferential wall strain measurement
gives a localized measure of arterial stiffness, while the goal of the PWV measurement
is a global measure. This global measure typically incorporates multiple bifurcations
which are more prone to atheroscerosis. We also recognize that the circumferential wall
strain measure is ideally repeated before the start of each PWV measurement. Wall
strain is affected by vascular state, which is known to change due to various
physiological states and can be influenced by medications.

3.6.3. Non-Invasive Measurements of Elastance
To assess arterial stiffness, the theoretical solution was introduced in an
alternative form, explicitly determining arterial compliance as a function of PWV, peak
pressure, ejection volume, and ejection time. To determine elastic modulus using the
contour plot generated by the theoretical model equation (3.25), shown in supplemental
material Figure 3.6, we simply need to know the previously stated measured inputs of
the corresponding waveform.
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Figure 3.6. Elastance contour plot for fixed ejection volume (66 ml) and peak pressure (140 mmHg). The
model calculated a 1.04 MPa elastic modulus based on the measured peak pressure, ejection time, and
PWV. The three annotated red diamonds are the model results using measurements taken at ejection
times (252, 297, 326). Each of these ejection times had a measured peak pressure of ~140 mmHg.

We used the hemodynamic simulators measured data for ejection times (252, 297, 326
ms) from Table 3.1. The output of the theoretical model was then compared against the
measured static elastance for the latex tube. The model calculated an elastance of
~1.04 MPa, with a worst-case percent difference of 2% when compared against the
static elastance for the three selected points. The result highlights the point that global
compliance was found with a PWV measure using our model.
Figure 3.7 presents contour lines for the correction coefficient C/CBH equation
𝑢0

(3.25) for compliance. Setting for instance typical values, 𝐴𝜂 = 0.05, 𝑐

𝑀𝐾

= 0.1, one can

quantify an asymptotic error in the compliance calculation based on equation (3.23) as
(𝐶 − 𝐶𝐵𝐻 )/𝐶𝐵𝐻 = 0.25. This means that equation (3.23) overestimates compliance at
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this point by ~25%. These new results suggest that Bramwell-Hill theory can
overestimate compliance by ~25% within the realistic range of physiological parameters.

Figure 3.7. Contour plot for the compliance correction coefficients C/CBH , calculated using the ratio of the
average flow velocity to the Moens-Korteweg speed (𝒖𝟎 /𝒄𝑴𝑲 ) equation (3.25). The lower lefthand corner
of the plot represents 𝑪𝑩𝑯 ( C/CBH=1).
.

Knowledge of these properties is clinically important for diagnosis and medical
treatment. A decrease in compliance is associated with increased central blood
pressure, cardiac afterload, cardiac energy requirements, and decreased coronary
perfusion (lower diastolic pressure) [6]. The inverse solution offers the possibility of
improving the accuracy of compliance measurement by incorporating the effects of peak
pressure and ejection time into the classical Bramwell-Hill compliance equation. The
transit time, required for the determination of PWV, can be measured between two flow
pulses simultaneously recorded by continuous Doppler probes or sequentially with ECG
gating. Measurements are usually made at the root of the left subclavian artery (i.e.,
suprasternal notch on the skin) and near the bifurcation of the abdominal aorta (i.e.,
umbilicus level on the skin) [24]. Transit time can be automatically calculated following
automatic recognition of the foot of the pulse. To correct for ejection time, both average
flow velocity and wall strain must be measured and applied to equation (3.16). Average
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flow velocity (u0) can be measured using Doppler ultrasound and peak circumferential
aortic wall strain (Aη); associated volume (V) can be measured using two-dimensional
ultrasound. These values can be used with the measured PWV in equation (3.16) to
determine cMK, which can then be used in equations (3.22) and (3.25) to determine the
aortic compliance.
While initial results are compelling, a complete in-vitro analysis using a range of
pressures and compliance is needed to validate this model. This work should also
include analysis using a more complex viscoelastic model of an arterial wall that
accounts for stress relaxation and possibly nonlinear behavior of the arterial wall.
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3.7.

Conclusion

A traveling wave-based mathematical approach was applied to predict the
dependence of PWV on the peak pressure wave and LVET. The presented model
incorporates nonlinear convection effects and the inertia of the vibrating wall. The model
showed that 12% of the observed change in PWV was caused by ejection time and that
2% of the observed change was caused by peak pressure alone. This insight is
important and explains why Nurenberg et al. [3] and Salvi et al. [5] observed that LVET
was a predictor of PWV. Our modeling and validation results contribute to the emerging
evidence that, both in clinical practice and in clinical research, cardiac systolic functionrelated variables should be regularly taken into account when interpreting arterial
function indices, namely PWV. A predictive model that provides mechanistic insight into
the nonlinear effects on PWV (average flow velocity and peak pressure) can be used for
future research both in vivo and in vitro. This work is expanded on in Chapter 4, in
which nonlinear, thin-walled elastic arterial segments are modelled. This work is also
applied in Chapter 6 to improve blood pressure prediction using systolic flow correction
of PWV.
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Chapter 4:

Pulse Wave Velocity Prediction in Nonlinear
Thin-Wall Elastic Arterial Segments

Science like life feeds on its own decay. New facts burn old rules; then newly developed concepts bind
old and new together into a reconciling law. - William James

4.1. Abstract
A new theoretical model for pulse wave propagation in a compliant arterial
segment is presented within the framework of pseudoelastic deformation of biological
tissue undergoing finite deformation. An essential ingredient is the dependence of
results on nonlinear aspects of the model: convective fluid phenomena, hyperelastic
constitutive relation, large deformation, and a longitudinal pre-stress load. An exact
analytical solution for PWV is presented as a function of pressure, flow, and
pseudoelastic orthotropic parameters. Results from the model are compared with
published in-vivo PWV measurements under diverse physiological conditions.
Contributions of each of the nonlinearities are analyzed. It was found that the
completely nonlinear model achieves the best match with the experimental data. To
retrieve individual vascular information of a patient, the inverse problem of
hemodynamics is presented, calculating local, orthotropic, hyperelastic properties of the
arterial wall. The proposed technique can be used for non-invasive assessment of
arterial elastance, and of blood pressure using direct measurement of PWV.
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4.2. Nomenclature
E
PWV
FSI
BP
A
u
p
ρ

R,r

η
𝑐𝑀𝐾
H, h
F
𝜎𝜃 , 𝜎𝑧
𝐺𝜃 , 𝐺𝑧

A
Subscripts
(r,θ,z)

Modulus of elasticity (Pa)
Pulse wave velocity (m/s)
Fluid structure interaction
Blood pressure
Cross-sectional area (m 2)
Axial flow velocity (m/s)
Transmural pressure (Pa)
Density of incompressible fluid (kg/m 3)
Internal wall radii at zero-stress and loaded conditions, respectively (m)
Ratio of the wall deflection to R
Moens-Korteweg speed of propagation (m/s)
Thickness of the wall at zero-stress and loaded conditions, respectively (m)
Axial pretension force (N)
Circumferential and axial Cauchy stress components (Pa)
Circumferential and axial Green-Lagrange strain components
𝑎11 𝑎12
[𝑎
]symmetric tensor of material constants (Pa)
12 𝑎22
Radial, circumferential, and axial components of a corresponding 3D vector
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4.3. Introduction
Historically, PWV has conceptually been based on the Moens-Korteweg
equation, which predicts PWV based on an acoustical approach applied to a fluid
structure interaction (FSI) of blood flow with a linear elastic cylindrical artery [1]. A
nonlinear traveling wave model was developed for a compliant thin-walled linear elastic
tube filled with an incompressible fluid [2,3]. This model accounts for the convective
ideal fluid flow interacting with a linearly elastic aortic vessel. However, assumptions
regarding linear deformation of an arterial vessel are not precisely applicable to living
blood vessels, as is proven in numerous related publications [1,4-14]. Nonlinearities in
blood vessel elasticity and finite deformation are vitally important to match static testing
results for an internal pressure load and an axial tension of a cylindrical artery under
physiological conditions [4-7].
The link between PWV or pulse transit time (PTT), and blood pressure (BP) has
previously been investigated based on statistical regression models, or empirical
representation of an incremental isotropic elastic modulus as a function of a transmural
pressure [15-18]. The model proposed here is a physics-based mathematical model that
predicts the general relationship between PWV and BP with a rigorous account of
nonlinearities in the fluid dynamics model, blood vessel elasticity, finite deformation of a
thin anisotropic wall, and a longitudinal pre-stress. The combined effect of BP and blood
flow on PWV is derived and agrees with clinical evidence presented in [4,5].
Contributions of the nonlinearity effect, between the published experimental data and
theoretical prediction, are analyzed. In order to retrieve the individual vascular
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information of a patient, a PWV-based solution for the inverse problem of
hemodynamics is used that calibrates the individual orthotropic hyperelastic arterial
properties, based on typical diagnostic measurements and an optimization technique.
For many materials, linear elastic models do not accurately describe the observed
material behavior. The most common example of this kind of material is rubber,
whose stress-strain relationship can be defined as nonlinearly
elastic, isotropic, incompressible, and generally independent of strain rate.
Hyperelasticity provides a means of modeling the stress-strain behavior of such
materials. This study is a continuation of the previous work [2,3] in the context of in-vivo
validation and application of the proposed methodology to continuous, noninvasive
blood pressure measurements. The proposed technique can be used for non-invasive
assessment of arterial elastance, directly related to the direct measurement of PWV,
accounting for hyperelastic orthotropic properties of a biological vessel.
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4.4. Theory
Dynamics of Incompressible Flow in a Compliant Vessel
One-dimensional models simulating blood flow in arteries effectively describe
pulsatile flow in terms of averages across the section flow parameters (systolic flow
velocity, diastolic flow velocity). The details of flow separation, recirculation, or shear
stress analysis are not calculated in one-dimensional models, but should accurately
represent the overall and average pulsatile flow characteristics (particularly PWV).
Derivations of one-dimensional models can be found in a number of papers, for
example [2,3,21], and are not repeated here.
Conservation of mass and momentum results in the following system of onedimensional equations:
𝜕𝐴
𝜕
+ (𝑢𝐴) = 0
𝜕𝑡
𝜕𝑧

(4.1)

(4.2)
𝜕𝑢
𝜕 𝑢2 𝑝
+ ( + ) =0
𝜕𝑡 𝜕𝑧 2 𝜌
The model described by equations (4.1) and (4.2) is applied exclusively to the large
arteries, where viscosity is important only in the regions of a boundary layer and has no
practical impact on PWV [22,23]. As it follows from monographs of Caro et al. [22] and
Li et al. [24], the introduction of viscoelastic, rather than elastic, vessel wall properties
results in a slight increase in wave speed, but noticeably affects the attenuation of a
waveform. For an impermeable thin-walled membrane, neglecting inertia forces, the
vessel pressure-strain relationship is maintained by equilibrium conditions as a function
p=p(η), based on relevant constitutive relations. Noting that 𝐴 = 𝜋𝑅 2 (1 + 𝜂), and
assuming that transmural pressure is a smooth function of a wall normal deflection
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(derivative 𝑝𝜂 = 𝜕𝑝⁄𝜕𝜂 exists at any point), the total system of equations can be
presented in the following non-conservative form:
𝜕𝑈
𝜕𝑈
+ 𝐻(𝑈)
=0
𝜕𝑡
𝜕𝑧

(4.3)

where

𝑢
𝜂
𝑈 = [ ] ; 𝐻 = [𝑝
𝜂
𝑢
𝜌

1+𝜂
2 ]

(4.4)

𝑢

The eigenvalues of 𝐻(𝑈) are real and distinct. PWV is associated with the forwardrunning wave velocity (i.e., the largest eigenvalue [26]); hence, it is identified as
(4.5)
1+𝜂
𝑃𝑊𝑉 = 𝑢 + √
𝑝
2𝜌 𝜂
The partial derivative 𝑃𝜂 indicates sensitivity of pressure with respect to the wall normal
deflection η, and it has a clear interpretation as tangent (incremental) moduli in finite
strain inelasticity. The system described by equations (4.1) and (4.2) is typically closed
by defining an explicit algebraic relationship between pressure and normal deflection.
For example, in case of small deformation and linear elastic response, where E is the
Young’s modulus, 𝑣 is Poisson’s coefficient, and pressure relates to the circumferential
strain η via

𝑝=

𝐸̅ 𝐻
𝑅

𝜂,

𝐸̅ =

𝐸

(4.6)

1−ν2

so that equations (4.4) and (4.5) can be transformed to the simplified form derived
differently in [2,3,21]
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(4.7)
𝐸̅ ℎ
𝑃𝑊𝑉 = 𝑢 + 𝑐𝑀𝐾 √1 + 𝜂, 𝑐𝑀𝐾 = √
2𝜌𝑅
Under the assumption 𝑢 ≪ 𝑐𝑀𝐾 , 𝜂 ≪ 1 (linearized approach), equation (4.7) converts
into the Moens-Korteweg equation for the forward- and backward-travelling waves. In
the general case, equation (4.5) should be supplemented by appropriate constituent
equations for a hyperelastic anisotropic arterial wall, accounting for finite deformation.

Hyperelasticity of the Vessel Wall
It is assumed that arterial wall is hyperelastic, incompressible, anisotropic, and
undergoing finite deformation. After a few original loading cycles (preconditioning), the
arterial behavior follows some repeatable, hysteresis-free pattern with a typical
exponential stiffening effect regarded as pseudoelastic [6,8]. Numerous formulations of
constitutive models for arteries have been proposed based on polynomials [9],
exponential functions [6,7,10,11], log functions [12], or their mixtures [14], applied to the
pseudoelastic strain-energy density formulation. In a comparison paper [13], it is
concluded that the exponential descriptor of the passive behavior of arteries, due to
Zhou-Fung, is “the best available”. According to Fung et al. [6,7,10], the strain energy
density function 𝑊 for the pseudoelastic constitutive relation may be presented in the
form
1
(4.8)
𝑐(𝑒 𝑄 − 1)
2
where c is a material coefficient, and Q is the quadratic function of the Green-Lagrange
𝑊=

strain components. For the finite inflation and extension of a thin-walled cylindrical
artery, the following strain energy function is used:
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𝑄 = 𝑎11 𝐺𝜃2 + 2𝑎12 𝐺𝜃 𝐺𝑧 + 𝑎22 𝐺𝑧2

(4.9)

where 𝑐, 𝑎11 , 𝑎12 , 𝑎22 are material constants. The Cauchy stress components in
circumferential and axial directions are:
𝜕𝑊
= 𝑐𝜆2𝜃 𝑒 𝑄 𝑆𝜃 , 𝑠𝜃 = 𝑎11 𝐺𝜃 + 𝑎12 𝐺𝑧
𝜕𝐺𝜃
(4.10)
𝜕𝑊
𝜎𝑧 = 𝜆2𝑧
= 𝑐𝜆2𝑧 𝑒 𝑄 𝑆𝑧 , 𝑠𝑧 = 𝑎12 𝐺𝜃 + 𝑎22 𝐺𝑧
𝜕𝐺𝑧
With the geometry of the reference state determined, we define R, Z, and H as an
𝜎𝜃 = 𝜆2𝜃

internal radius, axial coordinate, and a wall thickness in a stress-free configuration. We
define r, z, h as an internal radius, axial coordinate, and a wall thickness in a
physiologically loaded configuration. The corresponding principal stretch ratios are
𝜆𝜃 = 𝑟⁄𝑅 , 𝜆𝑧 = 𝑑𝑧⁄𝑑𝑍 , 𝜆𝑟 = ℎ/𝐻

(4.11)

Assuming isochoric deformation, incorporate the incompressibility condition as
𝜆𝑧 𝜆𝜃 𝜆𝑟 = 1

(4.12)

The Green-Lagrangian strain components relate to the principal stretch ratios of
equation (4.12) by
1
𝐺𝑖 = (𝜆2𝑖 − 1), (𝑖 = 𝜃, 𝑧, 𝑟)
2

(4.13)

For the membrane thin-walled cylindrical artery undergoing finite inflation and axial
deformation, the load-stress relations follow from the static conditions
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𝜎𝜃 =

𝑝𝑟 𝑝𝑅𝜆𝜃 𝑝𝑅 2
=
=
𝜆 𝜆
ℎ
𝐻𝜆𝑟
𝐻 𝜃 𝑧

(4.14)

𝐹

𝜎𝑧 = 2𝜋𝑅𝐻 𝜆𝑧 = 𝑓𝜆𝑧
A substitution back into equation (4.10) yields the desired relations:

𝑄
𝜆−1
𝑧 𝑐𝑒 𝑠𝜃 =

𝑝𝑅
ℎ
(4.15)

𝑄

𝜆𝑧 = 𝑐𝑒 𝑠𝑧 = 𝑓
The solution of equations (4.9), (4.13), and (4.15) results in a load-strain relation, which
with account of the identity

𝑟

𝜆𝜃 = 𝑅 =

𝑟−𝑅
𝑅

+ 1 = 𝜂 + 1 converts into 𝑝 = 𝑝(𝜂), required

by equation (4.5) to predict a wave front speed of propagation (i.e., PWV).

Numerical Computation of a Tangent Moduli in a Finite Strain Hyperelasticity
To solve the nonlinear deformation problem from equations (4.9), (4.13), and
(4.15), the theory of continuation method is applied [27]. It enables the transformation of
algebraic, functional, or differential equations into initial value problems by introducing a
parameter and embedding the particular problem into a family of relating parametric
problems. When the load parameter 0 ≤ 𝜏 ≤ 1 is introduced, and 𝑝 → 𝜏𝑝 is
substituted, 𝑓 → 𝜏 𝑓 describes a continuous successive loading on the vessel by
internal pressure 𝜏𝑝 and axial load 𝜏𝑓 from zero to nominal values. Assume the solution
to equation (4.15) depends continuously on load-strain and is differentiable with respect
to the parameter . Starting from the known answer for a certain value of the parameter
(𝜏 = 0 at a stress-free case), the solution to the equation for other values of the
parameter may be obtained by integrating the rate of change of the solution with respect
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to the parameter. To find the rate of strain components with respect to , take the natural
log of equation (4.15).

− ln 𝜆𝑧 + 𝑄 + ln 𝑠𝜃 = ln 𝜏 + 𝑙𝑛

𝑝𝑅
𝑐𝐻
(4.16)

ln 𝜆𝑧 + 𝑄 + ln 𝑠𝑧 = ln 𝜏 + ln 𝑓
and differentiate both sides (the dot above the variable means partial derivative by 𝜏),
which yields
𝑀(𝐺)𝐺̇ = 𝑏

(4.17)

where
2𝑠𝜃2 + 𝑎11
𝑀(𝐺) = [
2𝑠𝜃 𝑠𝑧 + 𝑎12

𝑠𝜃
+ 2𝑠𝜃 𝑠𝑧
1 + 2𝐺𝑧
],
𝑠𝑧
+ 2𝑠𝑧2 + 𝑎22
1 + 2𝐺𝑧
−

(4.18)

𝑠𝜃
𝐺
𝐺 = ( 𝜃 ) , 𝑏 = ( 𝑠𝜏 )
𝐺𝑧
𝑧
𝜏

 =0, a singular point results. To find the strain
As it follows from equation (4.18), when
𝜆𝑧 = 1 + 𝑂(𝜏), 𝑄 = 𝑂(𝜏 2 ), 𝑒 𝑄 = 1 + 𝑂(𝜏 2 )
rates at infinitesimally small  , the following asymptotic relations deduced from the
Taylor expansions in the proximity of a stress-free state (𝑂(… ) stands for the asymptotic
approximation)
𝐺𝜃 = 𝐺𝜃̇ 𝜏 + 𝑂(𝜏 2 ),
𝑠𝜃 = (𝑎11 𝐺𝜃̇ + 𝑎12 𝐺𝑧̇ )𝜏 + 𝑂(𝜏 2 ),

𝐺𝑧 = 𝐺𝑧̇ 𝜏 + (𝜏 2 )

(4.19)

𝑠𝑧= (𝑎12 𝐺𝜃̇ + 𝑎22 𝐺𝑧̇ )𝜏 + 𝑂(𝜏 2 )

𝜆𝑧 = 1 + 𝑂(𝜏), 𝑄 = 𝑂(𝜏 2 ), 𝑒 𝑄 = 1 + 𝑂(𝜏 2 )
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should be substituted into equation (4.15). As a result, the linear equation for the strain
rates at  =0, are 𝑀0 𝐸̇ (0) = 𝑏0 , where

𝑎11
𝑀0 = [𝑎
12

𝑝𝑅

𝑎12
𝑐𝐻
𝑎22 ] , 𝑏0 = ( 𝑓 )

(4.20)

𝑐

Once 𝐺 is known at 𝜏 = 0, equation (4.18) can be integrated to result in
𝐺(𝜏 + ∆𝜏) = 𝐺(𝜏) + 𝑀−1 (𝜏)𝑏(𝜏)Δ𝜏

(4.21)

The process continues to provide solutions for 𝜏 = 1. Once strain components
are known, the Cauchy stress components can be calculated from equation (4.14), and
stretch ratios and load-deflection relations can be calculated from equations (4.11) and
(4.13).
Alternative approaches to solving hyperelastic anisotropic finite strain problems
can be found in [28,29] using finite element approximations, and in [30,31], based on
finite difference methods.
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4.5. Methods
To validate the algorithm, the theoretical prediction of the relationship between
𝜕𝑊

circumferential Lagrangian stress component 𝑇𝜃 = 𝜆𝜃 𝜕𝐺 and circumferential stretch
𝜃

ratio 𝜆𝜃 is compared with experimental results in [7]. Zhou-Fung’s work was selected
because in a comparison paper [13] it is concluded that the exponential descriptor of the
passive behavior of arteries is “the best available”. Each loading curve corresponds to
𝜕𝑊

the constant value of an axial Lagrange stress component 𝑇𝑧 = 𝜆𝑧 𝜕𝐺 recorded in
𝑧

protocol 2, where the force in the longitudinal direction was held at 4 or 5 constant
levels. At each level, the force in the circumferential direction was cycled from the
preload to the maximum load and back to the preload in the triangular waveform at 0.05
Hz [7].
Four different models are compared for PWV prediction: the finite deformation
hyperelastic (FDH), small deformation hyperelastic (SDH), small deformation linear
elastic (SDE), and the Moens-Korteweg (MK) model. The first two models, FDH and
SDH, have the same set of variables specifying hyperelastic constants (c,a11,a12,a22)
within the frame of Fung’s model. SDE is obtained from Fung’s exponential model
accounting for the linear terms only in a Taylor series expansion of Fung’s exponential
function, presenting potential energy of deformation. The latter results in a quadratic
expression for the potential energy, typical for classical linear orthotropic theory of
elasticity. In this case, the number of varying parameters was reduced to three, where
coefficient c appears as the amplification factor for orthotropic constants a11, a12, and
a22. The Moens-Korteweg model is a classical model using a single elastic constant,
which is a priori independent of pressure.
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The FDH model is utilized to determine the material constants noninvasively
using PWV versus transmural pressure. Experimental data of Histand and Anliker
[33,34], who introduced short trains of artificial, high-frequency waves to measure their
propagation speed in canine aorta at different static pressures, was selected. This
experiment was selected because it recorded PWV over a wide range of pressures in
the aorta. The noninvasive extracted material constants for mongrel dogs are then
compared to an invasive method obtained from a biaxial static load of a canine aorta for
five mongrel dogs performed by Zhou-Fung [7].
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4.6. Results and Discussion
Algorithm Validation
The mechanical properties (c=124.5 kPa, a11=0.264, a12=0.379, a22=0.0461) are
identified in [7] from experimental data on mongrel dogs’ canine aorta, subjected to
inflation and longitudinal stretch within the physiological range. The theoretical curves,
calculated based on the algorithm described above, are shown in Figure 4.1 as
continuous lines. The stress-strain relationship recorded by protocol 2 in [7] is presented
by markers for different values of axial stress. The circumferential stress becomes
typically nonlinear around 𝜆𝜃 = 1.3, increasing its slope monotonically as shown in
Figure 4.1(a). The theoretical prediction is in good correspondence with experimental
data within the entire strain range, with the correlation coefficient R2 exceeding 0.99 for
all cases.
Contour lines of an overall residual √𝑅12 + 𝑅22 , where 𝑅1 and 𝑅2 are the individual
relative residuals of each of the equations (4.15), are presented in Figure 4.1(b). The
accuracy of numerical computation within physiological range of transmural pressure
and axial extension force is better than 1%, which justifies application of a numerical
scheme as in equation (4.21). An accurate quantification of arterial stiffness is a key
factor affecting precision of a PWV prediction.
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Figure 4.1. The model predictions of stiffness match experimental in-vivo data, which is essential for
accurate PWV determination. (a) Dependence of circumferential stress on circumferential stretch ratio
during inflation and extension. The comparison of the Zhou-Fung test to our model shows close
correlation, with R2=0.99. (b) Contour lines representing an overall residual of solved equations for
different combinations of transmural pressure and extension force.

Material Properties Identification
In order to find the relationship between PWV and BP, it is essential to identify the
associated material properties of the vessel. Typically, to identify material properties,
the fitting process is used, minimizing the least square difference between the
measured and predicted stress-strain (or load-displacement curves) [6,7,10]. A PWVbased methodology, evaluating arterial stiffness by minimizing the difference between
measured and model-based predicted wave velocities, is presented in [32]. The
theoretical model used in [32] is the Moens-Korteweg model, which is based on a linear
elastic behavior of the wall undergoing acoustic interaction with internal flow. As a
conclusion, the authors affirm “acceptable performance except the region of a soft wall.”
Due to the strong evidence of essential hyperelastic nonlinearities coupled with finite
deformations [3,25-37], no limitations are applied to the physical and geometric aspects
of an arterial wall deformation in the present work. The current chapter investigates a
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possibility for the arterial wall properties using a noninvasive PWV-based approach.
There is a noticeable formal similarity between material parameters identification
problems that are based on measurements of a static pressure versus stretch ratio, and
those that are based on a static pressure versus PWV. In both cases, the tangent
(incremental) modulus is a key factor affecting modeling. In both cases, the components
of Cauchy stress (𝜎𝜃 and 𝜎𝑧 ) contribute to the solution.
Histand and Anliker results are presented in [1,33,34], and they are reproduced
in Figure 4 by square markers as PWV plotted against a single independent variable transmural pressure. The theoretical model, recast in the form (𝜆𝜃 = 𝜂 + 1),
𝜆

𝑃𝑊𝑉 𝑚𝑜𝑑 = 𝑢 + √2𝜌𝜃 𝑝𝜂

(4.22)

is calibrated based on a subset of four experimental points (shown in Figure 4.2 by solid
squares) and verified across the total set of eight experimental points (shown by square
markers). The mean flow velocity u was estimated using the ratio of 𝑢 ⁄𝑃𝑊𝑉 = 0.2
recommended by T.J. Pedley [34]. The fitting process was based on minimization of the
sum of squares ∑𝑖 (𝑃𝑊𝑉𝑖𝑒𝑥𝑝 − 𝑃𝑊𝑉𝑖𝑚𝑜𝑑 )2, where 𝑃𝑊𝑉𝑖𝑒𝑥𝑝 and 𝑃𝑊𝑉𝑖𝑚𝑜𝑑 are the
measured and modeled pulse wave velocities corresponding with the i-th experimental
data point. The Nelder-Mead algorithm available from the MATLAB Optimization
Toolbox was utilized as an optimization tool. The Fung’s model material properties [ c,

a11, a12, a22] serve as control variables.
The dashed line in Figure 4.2 indicates theoretical prediction based on the totally
nonlinear model (i.e., hyperelastic characterization accounting for the finite
deformation). Using properties identified based on the totally nonlinear characterization,
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the partially nonlinear model, combining hyperelasticity with a small deformation, was
used to create a PWV distribution (shown by the solid line in Figure 4.2). Given the
material properties of an arterial wall, the chart indicates proximity of two models in
terms of PWV distribution.

Figure 4.2. The nonlinear model produced the best fit of the PWV vs. transmural pressure function. The
dashed line indicates the theoretical prediction. Square markers illustrate the total set of experimental
points [31,32]. Solid square markers correspond with the subset of experimental points used for
calibration. Using the properties extracted from the nonlinear model, the lower (solid) line shows the effect
on PWV using the partially nonlinear model, combining hyperelasticity with small deformation.

The quality of a fitting process accounting for different nonlinearities is presented
in Table 4.1, quantified in terms of the error function (sum of squares). Four different
models have been compared: the finite deformation hyperelastic (FDH), small
deformation hyperelastic (SDH), small deformation linear elastic (SDE), and the MoensKorteweg (MK) model. Material parameters have been identified for each model
independently, based on a best fit procedure. The SDE model is obtained from Fung’s
model, accounting for the linear terms only in a Taylor series expansion of Fung’s
exponential function (4.8) of a potential energy of deformation. The latter results in a
quadratic expression for the potential energy, typical for a classical linear orthotropic
theory of elasticity. In this case, the number of varying parameters was reduced to
three: c*a11, c*a12, and c*a22, since coefficient c appears only as the amplification
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factor for orthotropic constants a11, a12 and a22. The Moens-Korteweg model is a
classical model using a single elastic constant, which serves as a control variable. The
finite deformation hyperelasticity (FDH) model and small deformation hyperelasticity
(SDH) model have the highest quality of fitting, creating practically the same modelbased regression in Figure 4.2 within the physiological range of BP. The small
deformation with linear elasticity (SDL) model and Moens-Korteweg (MK) model cannot
be used to predict dependence of PWV on BP. Recall that the SDL model accounts only
for the convective flow type nonlinearity [3], whereas the MK model is a totally linear
model in which prediction of PWV is independent of pressure.
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Table 4.1. Contribution of nonlinearities to the quality of the best fit
Model
FDH
SDH
SDE
MK
Error Function

0.0147

0.0242

1.08

5.16

It is interesting to compare mechanical properties predicted using the PWVbased methodology applied to the FDH model, to those identified in vivo by traditional
static load. In [7] the thoracic aortas of five mongrel dogs were subjects of a mechanical
test in which each specimen was stretched biaxially. From the test measurements,
material constants from the Zhou-Fung hyperelastic model were obtained in [7] for
canine aortas of mongrel dogs using the least square minimization procedure. The
extraction of the corresponding five datasets from [7] fills the columns S1-S5 in Table
4.2. The last column represents the material properties of a canine aorta of a mongrel
dog, identified based on an experimentally measured PWV versus BP, obtained by
Histand and Anliker [33,34] and the current methodology.
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Table 4.2. Material constants, obtained from a biaxial static load of a canine aorta for five mongrel
dogs (cases S1-S5), performed by Zhou-Fung [7], and from the present results based
on data collected with PWV versus transmural pressure in mongrel dogs in [33,34].
Constants
S1
S2
S3
S4
S5
Present Result
c [mmHg]
901
945
372
1152
1297
1595
a11
0.320
0.289
0.338
0.175
0.200
0.1205
a22
0.451
0.397
0.441
0.314
0.292
0.8080
a12
0.068
0.073
0.010
0.041
0.039
0.001

It can be seen that the proximity of material properties predicted by the described
methodology and traditional static test in terms of PWV versus BP distributions are
similar. Figure 4.3 illustrates distributions of PWV for Zhou-Fung’s five static test cases
(S1-S5 columns in Table 4.2) and its counterpart relating to the properties extracted by
the present method (the last column of Table 4.2). Except for case S3, which is
characterized by an anomalously low material coefficient c, the relative variation in PWV
prediction does not exceed 4% of all other cases within the range of transmural
pressure presented in the figure.

Figure 4.3. The material properties of a canine aorta of mongrel dogs extracted from static measures [7]
predict PWV vs. BP distributions in close proximity to those extracted from direct PWV vs. BP
experiments [33,34]. S1-S5 and Present Result (PR)-associated material constants are shown in Table
4.2.

According to [35], longitudinal pre-stress may well play a dominant role in wall
stress distribution and effective arterial stiffness. To illustrate the effect of a longitudinal
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force on PWV, as a result of a numerical simulation, the variation of PWV due to the
variability of a longitudinal pre-stress force is presented in Figure 4.4. According to
simulation, within the realistic physiological range of a longitudinal stress [36], the
relative deviation in PWV does not exceed 3%.

Figure 4.4. Simulation results show that within a physiological range [36], longitudinal pre-stress load
affects PWV by ~3%. Tz denotes the axial physiological Lagrangian stress.

Stability of the Model Convergence
Theoretically, a least square procedure can lead to a non-unique set of material
parameters in the case of a non-convex objective function, when there are a large
number of control variables. In general, the problem depends on a convexity of an
objective function, and possibly on a particular least square numerical algorithm and
starting point of optimization. Stable convergence has been achieved using the NelderMead algorithm available from the MATLAB Optimization Toolbox. Different initial points
(corresponding with the five cases presented in Table 4.2) for numerical minimization
were used. In each case, all varying material constants, except a22, converged to the
same values, which are presented in the last column of Table 4.2. The quality of the fit
is characterized by the least square value 0.011 in each case. The coefficient a22 varied
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from 0.299 to 0.505, which did not affect the distribution of the PWV vs. transmural
blood pressure (i.e., the quality of the fit).

Prediction of Compliance and Distensibility of a Hyperelastic Segment
Arterial stiffness or its reciprocals (arterial compliance and distensibility) provide
an indication of vascular changes that predispose an individual to the development of
major vascular disease. In an isolated arterial segment filled with a moving fluid,
compliance is defined as a change in a volume V for a given change in pressure, and
distensibilty as compliance divided by initial volume [1]. As functions of pressure, the
local (tangent) compliance C and distensibility D are defined as [37]
𝑑𝑉

𝐶

𝑑𝑉

(4.23)

𝐶 = 𝑑𝑃 , 𝐷 = 𝑉 = 𝑉𝑑𝑃

Equations (4.23) determine arterial wall properties as local functions of transmural
pressure, contrary to the assessment using the diastolic-systolic pulse pressure.
It is possible to write equations (4.23) in the following equivalent form:
𝑑𝑉 ⁄𝑑𝜂

𝐶 = 𝑑𝑃⁄𝑑𝜂 =

2𝑉
𝑃𝜂

𝐶

2

,𝐷 = 𝑉 = 𝑃

(4.24)

𝜂

For the linear elastic response and small deformation, as it follows from equations (4.6),
(4.7),
𝑃𝜂 =

𝐸𝐻
𝑅

2
= 2𝜌𝑐𝑀𝐾

(4.25)

which in turn transforms Equation (4.24) to the classical Bramwell-Hill relations [1]
𝑉

𝑉

𝑀𝐾

𝑀𝐾

𝐶 = 𝜌𝑐 2 , 𝐷 = 𝜌𝑐 2

(4.26)

Generalization of a Bramwell-Hill equation, based on an empirical exponential
relationship between transmural pressure and a cross-sectional area, was presented in
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[34]. Classical results are generalized and discussed for the case of a hyperelastic
arterial wall, accounting for finite deformation and flow velocity.
It is possible to determine 𝑝𝜂 from equation (4.5) and then substitute it into equation
(4.23), arriving at the following relations:
1+𝜂

𝐷 = 𝜌(𝑃𝑊𝑉−𝑢)2 , 𝐶 = 𝑉𝐷

(4.27)

Figure 4.5 illustrates the dependency of distensibility on pressure and flow velocity.
Because PWV is monotonically increasing with pressure, distensibility is a decreasing
function. In the classical Bramwell-Hill model (which is linked to the Moens-Korteweg
model), wave speed predicts arterial distensibility as a constant, irrespective of the
pressure level. By contrast, the present model predicts distensibility as a function of
PWV, pressure, and blood flow.

Figure 4.5. Dependence of distensibilty on transmural pressure and a flow velocity.
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4.7. Conclusion
A physics-based model predicting PWV in compliant arterial segment is
presented within the framework of pseudoelastic deformation of biological tissue
undergoing finite deformation. The model is a natural generalization of a MoensKorteweg-Hughes family of equations [1], which accounts for the constant Young’s
modulus, or exponentially increasing elasticity as a function of BP. The model was
analyzed and validated across the available in-vivo experimental data. The method
shows potential to be used for non-invasive continuous long-term blood pressure
monitoring. This work is expanded upon in Chapter 5, in which nonlinear thick-wall
elastic arterial segments are modelled.
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Chapter 5:

Pulse Wave Velocity Prediction in Nonlinear
Thick-Wall Elastic Arterial Segments

‘Principles’ and ‘Reasons’ underlie all good practice. ‘Evidence’ follows. - William W. Nichols,
Michael F. O’Rourke
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5.1.

Abstract

Pulse wave velocity (PWV) is an important index of arterial hemodynamics,
which lays the foundation for continuous, noninvasive blood pressure automated
monitoring. Chapter 4 described a nonlinear thin-walled arterial segment with
predictions of PWV. The goal of this chapter is to examine the accuracy of PWV
prediction based on a homogeneous structural model for thin-walled arterial segments
and compare it to the thick wall model. In reality, arteries are described as composite
heterogeneous hyperelastic structures, in which the thickness dimension cannot be
considered small compared to the cross section size. In this chapter, a hemodynamic
fluid-structure interaction model accounting for the variation of geometry and material
properties in a radial direction is presented. The model is suitable to account for the
highly nonlinear orthotropic material undergoing finite deformation for each layer.
Numerical analysis of one- and two-layer arterial segments shows that a single layer
thick model provides sufficient accuracy to predict PWV. The dependence of PWV on
pressure for three vessels of different thicknesses is compared against our thin wall
model of a membrane shell interacting with an incompressible fluid described in Chapter
4. The presented thick wall model provides greater accuracy in the prediction of PWV,
and it will be important for blood pressure estimation based on PWV measurements.
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5.2.
A
A
𝐺𝜃 , 𝐺𝑧
H
p
Q
𝑅𝑖 , 𝑅𝑒
u
W
𝛿𝛼𝛽
η
𝜆𝑟 , 𝜆𝜃 , 𝜆𝑧
ρ
𝜎𝜃 , 𝜎𝑟

Nomenclature
𝑎𝜃𝜃 𝑎𝜃𝑟
[𝑎
𝑎𝑟𝑟 ] Symmetric tensor of material constants
𝜃𝑟
Cross-sectional area (m 2)
Circumferential and radial Green-Lagrange strain components, respectively
Arterial wall thickness (m)
Transmural pressure (Pa)
Quadratic function of the Green-Lagrange strains
Internal and external wall radii in a zero-stress condition, respectively (m)
Axial flow velocity (m/s)
Strain energy density function
Kronecker delta: is 1 if the variables are equal, and 0 otherwise
Ratio of the wall internal surface normal displacement to the related radial coordinate
(𝑟)
Stretch ratios in radial, circumferential, and axial directions, respectively
Density of incompressible fluid (kg/m 3)
Circumferential and radial Cauchy stress components (Pa), respectively
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5.3.

Introduction

The potential of estimating arterial blood pressure based on PWV has been
investigated in a number of publications considering a linearized acoustical approach
(Moens-Korteweg equation), or its empirical generalization, introducing exponential
presentation of the Young’s modulus as a function of a blood pressure (BP) [1-3]. A
physics-based characterization built by modeling arteries as fluid-filled compliant thinwalled cylindrical membrane shells is presented in Chapters 3 and 4 [4,5]. The present
chapter describes a mathematical model predicting PWV propagation with rigorous
account of nonlinearities in the fluid dynamics model, blood vessel elasticity, and finite
dynamic deformation of multi-layer thick-wall arterial segments. This model is validated
within the context of published vessel characteristics and finite element simulations, with
extension to PWV and application to continuous, noninvasive blood pressure
measurements.

Figure 5.1. The anatomy of the aortic wall.
In the present work, the arterial wall is considered as a heterogeneous
composite, hyperelastic structure. Healthy arteries are composed of three distinct
layers: the tunica intima (the innermost layer), the tunica media (the middle layer), and
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the tunica adventitia (the outer layer), as shown in Figure 5.1. A material description for
each layer without thin-wall assumptions is presented, based on a material description
of an artery in a passive state originally proposed by Zhou and Fung [6]. A novel
mathematical model predicting PWV is proposed, accounting for nonlinear aspects of a
convective fluid phenomena, hyperelastic constitutive relations, and finite deformation of
a thick arterial wall. The errors introduced by the “thin-” walled assumptions have been
explored by Bergel [7] based on a linear elastic model for the vessel walls undergoing
small deformations. The present work extends this analysis by accounting more
accurately for material properties in arterial hydro-elastodynamics and by comparing the
proposed model against our thin wall model described in Chapter 4.
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5.4.

Theory

5.4.1. Fluid-Structure Interaction Model
One-dimensional models simulating blood flow in arteries effectively describe pulsatile
flow in terms of averages across the section flow parameters. Although they are unable
to provide the details of flow separation, recirculation, or shear stress analysis, they
should accurately represent the overall and averaged pulsatile flow characteristics,
particular PWV. Building on the derivation of dynamics of incompressible flow in a
compliant thin wall vessel detailed in Chapter 4, section 4.4.1 and references [4,5], the
mechanical framework for the thick wall is now considered. For the membrane thinwalled cylindrical artery undergoing finite inflation and axial deformation, the load-stress
relations follow from the static conditions. Finite deformation of a thick arterial wall is
now considered, and the physical relationships for Cauchy stresses and Green strains
are derived.
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5.5.

Mechanical framework

Consider an axisymmetric case with polar coordinate R describing material point in a
load-free state (Lagrangian frame of reference), and a polar coordinate r = r(R)
associated with a moving particle (Eulerian description) – in a deformed state. Axial
tethering is not considered here, and axial strain component is neglected. The
corresponding principal stretch ratios 𝜆𝑟 , 𝜆𝜃 and the Green strains 𝐺𝑟 , 𝐺𝜃 , are considered
[8].
𝑑𝑟

𝑟

1

𝜆𝑟 = 𝑑𝑅 , 𝜆𝜃 = 𝑅 , 𝐺𝛼 = 2 (𝜆2𝛼 − 1), (𝛼 = 𝑟, 𝜃)

(5.1)

Numerous formulations of constitutive models for arteries have been proposed in
the literature. In a comparison paper [10], it is concluded that the exponential descriptor
of the passive behavior of arteries, due to Zhou-Fung, is “the best available”. According
to Zhou-Fung [6], the strain energy density function for the pseudoelastic constitutive
relation may be presented in the form

𝑊=

1
𝑐(𝑒 𝑄 − 1)
2

(5.2)

where c is the material coefficient, Q is the quadratic function of the Green-Lagrange
strains 𝐺𝑟 , 𝐺𝜃 , and material parameters tensor 𝑨 [6]. The thick wall model uses tensor A
material parameters described by 𝑎𝜃𝜃 , 𝑎𝜃𝑟 , 𝑎𝑟𝑟 . For the finite inflation and extension of a
thin-walled cylindrical artery in Chapter 4, equation (4.9) material constants
𝑐, 𝑎11 , 𝑎12 , 𝑎22 were used. The quadratic function of Green-Lagrange strains is described
as
𝑄 = 𝑎𝜃𝜃 𝐺𝜃2 + 2𝑎𝜃𝑟 𝐺𝜃 𝐺𝑧 + 𝑎𝑟𝑟 𝐺𝑧2

(5.3)
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For infinitesimally small strains, the exponential form of energy function is reduced to
the following quadratic form that relates to the plane theory of linear anisotropic
elasticity.
1
𝑐
𝑄2
𝑐
𝑊 = 𝑐(𝑒 𝑄 − 1) = (𝑄 +
+ ⋯ ) ≅ (𝑎𝜃𝜃 𝐺𝜃2 + 2𝑎𝜃𝑟 𝐺𝜃 𝐺𝑧 + 𝑎𝑟𝑟 𝐺𝑧2 )
2
2
2!
2

(5.4)

The Cauchy-Green stress components are defined as the following [6]:
𝜕𝑊
= 𝑐𝜆2𝜃 𝑒 𝑄 𝑆𝜃 , 𝑆𝜃 = 𝑎𝜃𝜃 𝐺𝜃 + 𝑎𝜃𝑟 𝐺𝑟
𝜕𝐺𝜃
𝜕𝑊
𝜎𝑟 = 𝜆2𝑟
= 𝑐𝜆2𝑟 𝑒 𝑄 𝑆𝑟 , 𝑆𝑟 = 𝑎𝜃𝑟 𝐺𝜃 + 𝑎𝑟𝑟 𝐺𝑟
𝜕𝐺𝑟

𝜎𝜃 = 𝜆2𝜃

(5.5)

Neglecting inertia forces, the problem of an artery subjected by transmural
pressure is described by solving the equation of equilibrium in an Eulerian frame [8]
𝜕𝜎𝑟 𝜎𝑟 − 𝜎𝜃
+
=0
𝜕𝑟
𝑟

(5.6)

that could be transformed to the Lagrangian coordinates using equation (5.1)
𝜕𝜎𝑟 𝜆𝑟 (𝜎𝑟 − 𝜎𝜃 )
(5.7)
+
=0
𝜕𝑅
𝜆𝜃 𝑅
Note that an additional equation for the strains, known as the compatibility equation,
follows from equation (5.1)
𝜕𝜆𝜃 𝜆𝑟 − 𝜆𝜃
=
𝜕𝑅
𝑅

(5.8)

or, in terms of the circumferential Green strain component
𝜕𝐺𝜃
𝜆𝑟 − 𝜆𝜃
= 𝜆𝜃
= 0.
𝜕𝑅
𝑅

(5.9)

The boundary conditions for the internal and external radii of the artery are
𝜎𝑟 (𝑅𝑖 ) = −𝑝, 𝜎𝑟 (𝑅𝑒 ) = 0.

(5.10)
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Equations (5.1), (5.5), (5.7), and (5.9) and the boundary conditions defined in equation
(5.10) allow components of stress, strain, and stretch ratios as functions of a transmural
pressure, as well as incremental moduli of hyperelastic finite deformation (required by
equation 4.5) to predict a wave front speed of propagation (i.e., PWV).
In view of numerical analysis, we have to derive the tangent moduli (D) by differentiation
of a stress-strain relationship (12) (𝛿𝛼𝛽 - Kronecker delta: is 1 if the variables are equal
and 0 otherwise)

Dαβ =

∂σθ
2Sα
= cλ2α eQ (aαβ + 2Sα Sβ + 2 δαβ ) ,
∂Gβ
λα

α, β = r, θ

(5.11)

5.5.1. Continuation Method for the Nonlinear Boundary Value Problem
The theory of the continuation method enables the transformation of a boundary
value problem into an initial value problem, by introducing a parameter and changing it
into a family of parametric problems [9]. Assuming a load parameter 0 ≤ 𝜏 ≤ 1 and
substituting → 𝜏𝑝 , it is possible to model the continuous successive load on a vessel
with an internal pressure ranging from 0 to a nominal value. Assume that the solution of
equations (5.1) through (5.10) depends continuously on this parameter and is
differentiable with respect to this parameter. Starting from the known answer for a
certain value of the parameter (𝜏 = 0 in the present case), the solution of the equation
for other values of the parameter may be obtained by integrating the rate of change of
the solution with respect to the parameter.
Differentiating constituent equations (5.5) by the continuation parameter (the dot above
means partial derivative with respect to 𝜏), yields
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𝜎𝛼̇ = ∑ 𝐷𝛼𝛽 𝐺̇𝛽 , 𝛼, 𝛽 = 𝑟, 𝜃

(5.12)

𝛽

To solve the problem numerically, select the vector variable 𝒁 = (𝜎𝑟 , 𝐺𝜃 )𝑇 as the primary
variable in the model, because it preserves continuity for the multilayered structure with
discontinuous mechanical properties. The rate of “discontinuous” variables 𝑌 =
(𝜎𝜃 , 𝐺𝑟 )𝑇 follows from equation (5.12) accordingly
−1 det(𝑫) 𝐷𝑟𝜃
𝒀̇ = 𝑩𝒁̇, 𝑩 = 𝐷𝜃𝜃
(
)
−𝐷𝜃𝑟
1

(5.13)

To differentiate equation (5.7) by 𝜏, expand the logarithm of the right part 𝐹 =
𝜆𝑟 𝜆−1
𝜃 (𝜎𝜃 − 𝜎𝑟 )/𝑅
ln 𝐹 = ln 𝜆𝑟 − ln 𝜆𝜃 + ln(𝜎𝜃 − 𝜎𝑟 ) − ln 𝑅

(5.14)

and take derivatives of both sides
𝑑𝜎̇𝑟
𝐺̇𝑟 𝐺̇𝜃 𝜎̇𝜃 − 𝜎̇𝑟
= 𝐹̇ = 𝐹 ( 2 − 2 +
)
𝑑𝑅
𝜆𝑟 𝜆𝜃 𝜎𝜃 − 𝜎𝑟

(5.15)

Using a similar procedure, applied to the compatibility equation, yields equation (5.16)
𝑑𝐺̇ 𝜃
𝜆𝜃
𝜆𝑟
2
=
𝐺̇𝑟 + (
− )𝐺̇𝜃
𝑑𝑅
𝑅𝜆𝑟
𝑅𝜆𝜃 𝑅

(5.16)

Now equations (5.15) and (5.16) could be presented in a matrix form
𝑑𝒁̇
= 𝑪1 𝒁̇ + 𝑪2 𝒀̇
𝑑𝑅

(5.17)

in which
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𝐶1 =

−𝐹
𝜎𝜃 − 𝜎𝑟
0

−𝐹
𝜆2𝜃
𝜆𝑟
2
−
𝑅𝜆𝜃 𝑅 )

; 𝐶2 =

−𝐹
𝜎𝜃 − 𝜎𝑟
0

−𝐹
𝜆2𝑟
𝜆𝜃
𝑅𝜆𝑟 )

(5.18)

(
(
substituting equation (5.13) into equation (5.17) arrives at the final differential equation
𝑑𝑍̇
= 𝑪𝒁̇, 𝑪 = 𝑪1 + 𝑪2 𝑩
𝑑𝑅

(5.19)

with the boundary conditions, obtained by differentiation of the boundary conditions in
equation (5.10). (Note that pressure in equation (5.10) is being multiplied by τ, and 𝑰 =
[1 0].)
𝑰 ∙ 𝒁(𝑅𝑖 )=-p; I∙ 𝒁(𝑅𝑒 ) = 0

(5.20)

The initial parameter method presumes the solution of the linear boundary value
problem described in equation (5.19) to be represented in the form
𝒁̇ = 𝒁̇1 + 𝜇𝒁̇2

(5.21)

Here the vector functions 𝒁̇1 , 𝒁̇2 are independent solutions of equation (5.19) with the
following initial conditions
𝒁̇1 (0) = (−𝑝 0)𝑇 , 𝒁̇𝟐 (0) = (0 1)𝑇

(5.22)

and μ is an unknown constant determined from the second boundary condition in
equation (5.20).

𝜇=−

𝑰 ∙ 𝒁1 (𝑅e )
𝑰 ∙ 𝒁2 (𝑅e )

(5.23)

Once 𝒁̇ is known at 𝜏 = 0, then vector 𝒁 of continuous variables and vector 𝒀 of
discontinuous functions could be calculated by integrating the relating rate of change
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𝒁(𝜏 + ∆𝜏) = 𝒁(𝜏) + 𝒁̇(𝜏)Δ𝜏
(5.24)
𝒀(𝜏 + ∆𝜏) = 𝒀(𝜏) + 𝑩𝒁̇(𝜏)Δ𝜏
The above process continues to obtain solutions for τ = 1. The pressure versus normal
displacement 𝑝 = 𝑝(𝜂) is tracked at 𝑅 = 𝑅𝑖 for each level of successively increasing
load to create an incremental moduli 𝑝(𝜂) function, required by equation (4.5) to predict
a wave front speed of propagation (i.e., PWV).
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5.6.

Results and Discussion

To validate the algorithm, the numerical investigation of an inflated rabbit carotid
arterial segment is presented and compared with the results based on a finite element
analysis, obtained by Holzaphel et al. [10]. The rabbit arterial data presented by Chuong
and Fung [11]: c=26.95kPa; 𝑎𝜃𝜃 = 0.9925, 𝑎𝜃𝑟 = 0.0193, 𝑎𝑟𝑟 = 0.0089, Ri=0.71 mm, Re
= 1.1 mm (from experiment number 71) is used. Figure 5.2 (a) shows the predicted
mechanical response of the considered artery. Squares relate to the finite element
analysis [10] and are in good agreement with the results based on our present single
layer thick wall model. The derivative 𝑝𝜂 of pressure by radial displacement of an
internal surface (i.e., hyperelastic incremental moduli), presented in Figure 5.2 (b), is a
primary factor affecting PWV in a cylinder filled with a moving fluid according to
equation (4.5). At diastolic pressure when flow is close to zero, PWV is dominated by
the physical anisotropic properties of the aorta. At systolic pressure, the pulse wave
velocity is also affected by flow velocity, which may be approximated as 20-25% of
PWV according to Pedley [15].

121

Figure 5.2. Mechanical response of a carotid artery from a rabbit during inflation. a) depicts the
dependence of the inner diameter on internal pressure. The solid line is a prediction based on our singlelayer thick wall model that is in good correlation with the results (squares) from [10]. b) depicts
incremental moduli 𝑝𝜂 of the hyperelastic artery (i.e., derivative of a pressure by the radial displacement
𝜂).

A single layer thick wall model with homogeneous mechanical properties does
not account for the distinct mechanical response of the separate layers (intima, media,
and adventitia). Since the intima contributes negligible mechanical strength [10], a twolayer model, incorporating media and adventitia only, is analyzed. Following [10,12],
assume that media occupies approximately 0.6 of the arterial wall thickness.
Experimental tests indicate that media is about ten times stiffer that adventitia [12,13],
which allows to scale accordingly material properties tensor A. Figure 5.3 depicts
predicted mechanical response of the considered artery, calculated based on a single
layer thick wall model (dashed lines) and a two-layer-thick wall model (solid lines). The
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circumferential Cauchy stress is plotted in Figure 5.3 (a), normal displacement in Figure
5.3 (b), and radial component of Green strain in Figure 5.3 (c), all against the radial
coordinate. The abrupt change in mechanical properties at the boundary between
media and adventitia results in a sharp discontinuity of circumferential stress and radial
strain components. Radial displacement is a continuous function, deviating slightly from
the single-layer counterpart as shown in Figure 5.3 (b). In the proximity of the internal
cylindrical surface, distributions of all parameters calculated by both models (1 layer, 2
layers) are identical as seen in Figure 5.3. Since PWV is determined by the local wall
stiffness, relating to the internal cylindrical surface, the latter justifies application of the
single layer thick model to the PWV-related problems.

Figure 5.3. Single layer thick wall model (dashed line) is as accurate for PWV prediction as the two-layer
thick wall model (solid line) and avoids associated discontinuities. Plots of circumferential Cauchy stress
(a), normal displacement (b), and radial component of a Green strain (c) through the wall thickness. For
the two-layer model, the light gray represents the media and the dark gray represents the adventitia layer.
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Figure 5.4 depicts the dependence of PWV on pressure for the systole phase
(marked as “SBP”) and a diastole phase (marked as “DBP”) for three vessels of
different thicknesses of a human aorta. The anisotropic material constants for a human
aorta with an outer radius of 14.5 mm are taken from Fung et al. [14]. The inner radius
is then set based on the three wall thicknesses considered in Figure 5.4. Following [15],
assume here that the flow velocity u = 0 for the diastole phase and that it is equal to
20% of PWV for the systole phase. All results have been compared with the simplified
thin-walled model of a membrane shell interacting with an incompressible fluid [5].
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Figure 5.4. PWV curves for systolic blood pressure (SBP) and diastolic blood pressure (DBP) for the
nonlinear single layer thin and thick aortic wall. Figure 5.4 (a) corresponds to the vessel thickness of
H = 4 mm, H/Ri = 0.38; Figure 5.4 (b) to H = 2.5 mm, H/Ri = 0.21; Figure 5.4 (c) to H = 1 mm,
H/Ri = 0.07; Figure 5.4 (d) to the percent difference between the thin and thick wall model predictions at
SBP/DBP = 150/95 mmHg for PWV (solid line) and blood pressure (dotted line).
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The analysis presented in Figure 5.4 considers normal wall thicknesses of less than
4 mm [16] across a range of transmural blood pressures. To explore inaccuracies
induced by use of the less complex thin wall model, errors in both PWV and blood
pressure were calculated for a blood pressure of SBP/DBP = 150/95 mmHg,
representing the median of stage 1 hypertension [17]. The single layer thick wall model
improves PWV accuracy by 4.0-8.4% across a range of normal wall thickness. One of
the goals for the model is PWV-based blood pressure prediction, where the thick wall
model offers an improvement of 3.3-19.4%. Accuracy improvements are highly
dependent on the relative dimensions of wall thickness to arterial radius. As the ratio of
H/Ri approaches zero, the error of PWV prediction approaches zero, showing an
asymptotic accuracy as an order of wall thickness to internal radius ratio.
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5.7.

Conclusion

A novel mathematical model predicting PWV propagation with rigorous account
of nonlinearities in the fluid dynamics model, blood vessel elasticity, and finite
deformation of multi-layer thick-wall arterial segments was studied. It was found that the
account for the multilayer model affects distribution of local parameters in the proximity
of the external layer (adventitia) and does not affect stiffness related to the internal
layer. The latter means that the single layer thick model is sufficient to predict PWV of
an arterial segment. For a hypertensive subject, the three-dimensional thick- wall model
provides improved accuracy up to 8.4% in PWV prediction over its thin-wall counterpart.
This translates to nearly 20% improvement in blood pressure prediction based on a
PWV measure.
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Chapter 6: Improved Blood Pressure
Prediction Using Systolic Flow Correction
of Pulse Wave Velocity
Hence, the more rapidly moving elements of a wave will tend to catch up to those which are moving more
slowly; in other words the wave will tend to become more vertical, and, under suitable conditions, parts of
it may actually tend to topple over and form "breakers." - J. Crighton Bramwell and A. V. Hill; July 7, 1923

6.1 Abstract
Hypertension is a significant worldwide health issue. Continuous blood pressure
monitoring is important for early detection of hypertension and for the improvement of
treatment efficacy and compliance. Pulse wave velocity (PWV) has the potential to allow
for a continuous blood pressure monitoring device; however, published studies
demonstrate significant variability in relating PWV to blood pressure. In Chapters 3, 4,
and 5, the presented physics-based mathematical models of PWV describe how flow
velocity is additive to the classic pressure wave as estimated by arterial material
properties. This suggests flow velocity correction may be important for cuff-less noninvasive blood pressure measures. The present study examined the impact of systolic
flow correction of a measured PWV on blood pressure prediction accuracy using data
from two published in vivo studies. Both studies examined the relationship between
PWV and blood pressure under pharmacological manipulation, one in mongrel dogs
and the other in healthy adult males. Systolic flow correction of the measured PWV
improves the R2 correlation with blood pressure from 0.51 to 0.75 for the mongrel dog
study, and from 0.05 to 0.70 for the human subjects study. The results support the
hypothesis that systolic flow correction is an essential element of non-invasive, cuff-less
blood pressure estimation based on PWV measures.
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6.2 Introduction
Pulse wave velocity (PWV) is a non-invasive measure that offers the promise to
continuously monitor blood pressure and has been studied extensively [4-7]. The PWV
is calculated based on a measured true transit time (TT) and an arterial distance
between measurement points, as shown in Figure 6.1. Measurements may be at two
locations on the same artery, or often the electrocardiogram (ECG) R-wave is used as a
starting reference combined with a distal measurement point with or without correction
for pre-ejection period (PEP). While many studies consider only TT, it may be
considered an equivalent corollary to PWV because these measures are linked through
a distance that is constant within each study.
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Intra-arterial PWV
Gold-standard
Invasive Method

Alternative
Method

Distance

Simultaneous pressure
recorded invasively with
pressure sensors just
before the aortic root [a]
and above the aortic
bifurcation [b]
Sequential ECG-gated
recordings, just before the
aortic root [a] and above
the aortic bifurcation [b]
Length measured by
radiographic images or
catheter lengths

Non-invasive PWV
Gold-standard
Method
Alternative
Method

Distance

Simultaneous carotid [c]
and femoral artery
tonometry [d]
ECG R-wave, impedance
plethysmography for PEP,
and distal pulse wave at
the index finger [e]
Length measured from the
sternal notch to the
femoral artery at the groin
or index finger

Figure 6.1. Illustration of measurement methods used for PWV and the associated anatomical locations.

Bramwell and Hill recognized that an increase in pressure increases the pulse
wave velocity. They concluded that the foot-to-foot wave velocity increased proportional
to diastolic pressure [11,12]. In their innovative experiment, they replaced blood with
mercury to reduce wave velocity. This enabled accurate measurement of PWV in an
excised human carotid artery. Varying pressure from 20 mmHg to over 200 mmHg, they
found an exponential relationship between PWV and pressure. Continuing experiments,
where the velocity of different points on the pressure wave were measured optically and
with a sphygmograph, suggests that the systolic peak of the pressure pulse travels at
higher velocity than the diastolic foot [12]. Histand and Anliker superimposed a lowamplitude pulse train directly on the aorta to enable PWV calculations at different
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locations on the pulse wave (SBP, DBP) [13]. They found a wave speed change of
~30% between diastole and systole. The interesting implication is that pressure pulse
foot-based PWV estimations are likely correlated with diastolic pressure, an implication
supported by in vivo studies. Researchers have used this knowledge and empirically
modified the cMK equation (1.1) to use the dynamic Young’s modulus equation (1.2) to
incorporate blood pressure into the Moens-Korteweg equation [10,14].
Payne et al. conducted an in vivo study to determine the correlation between
blood pressure and transit time in twelve healthy men [15]. Four vasoactive drugs
(glycerol trinitrate, angiotensin II, norepinephrine, and salbutamol) were administered
intravenously to modulate physiological state. Two types of transit time were
considered: ECG R-wave to the foot of the distal pulse wave (rPTT), and ECG R-wave
to the foot of the distal pulse wave minus PEP to provide an estimate of TT. In both
cases, the distal pulse wave was measured using photoplethysmography at the
dominant index finger. They found TT was most closely correlated with diastolic blood
pressure (DBP) R2=0.85, while rPTT was most closely correlated with systolic blood
pressure (SBP) R2=0.39.
Ochiai et al. conducted a similar in vivo study with ten mongrel dogs that
determined the correlation between blood pressure and PWV [16]. Hypertension was
induced by continuous infusion of dobutamine and phenylephrine; hypotension was
induced by deepening isoflurane anesthesia, acute blood loss, and nitroglycerine
infusion. Two types of transit time were considered: rPTT measured by the ECG Rwave to the foot of the pressure wave measured at the bifurcation of the abdominal
aorta, and TT measured by the pressure wave at the ascending aorta to the pressure
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wave measured at the bifurcation of the abdominal aorta. Two intra-arterial catheter tip
pressure transducers were placed distal to the aortic root and abdominal aorta
bifurcation as shown in Figure 6.1, locations a and b, respectively. They found that TT
was most closely correlated with both DBP (R2=0.92) and SBP (R2=0.81) across all
conditions. The correlation of TT with both DBP and SBP, and rPTT with SBP (R2=0.59)
were higher for Ochiai et al. than the correlations found by Payne et al., likely due to the
internal aortic measurement locations. It is known that some of the drugs used in the
studies affect the elastic arteries differently than the muscular arteries [17].
Nitroglycerin, for example, produces a peripheral vascular effect by relaxing the smooth
muscle. The mid-sized peripheral arteries are muscular in nature and thereby
susceptible to nitroglycerin action.
Other studies have considered the effect of left ventricular ejection time (LVET)
and its relationship to pressure and PWV [6,18,19]. Nurnberger et al. conducted a study
of young, healthy males to determine if LVET was a determinant of PWV [6]. He studied
102 subjects under resting conditions and then six subjects under stimulation of β- or αadrenoreceptors. They found that LVET may be an important determinant of PWV
under resting conditions and adrenergic conditions in healthy young males. A similar
study over a large population of 3020 untreated subjects was conducted by Salvi et al.
[19]. They found an inverse linear association between PWV and LVET across all five
age groups (<25yrs, 25-44yrs, 45-64yrs, 65-84yrs, and >85 yrs.; p < 0.0001, R2=0.35).
In Chapters 3-5, a nonlinear traveling wave-based mathematical approach to
predict the dependence of PWV on transmural pressure and LVET was developed. This
first principles model reduces to the Moens-Korteweg speed of propagation under
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conditions of linear elasticity and zero pressure. An in-vitro cardiovascular
hemodynamic simulator was used to validate the theoretical predictions confirming an
inverse quadratic relationship between LVET and PWV [20]. However, the fundamental
equations suggest that it is flow velocity and the properties of the aortic wall, and not
LVET explicitly, that influence PWV in arterial segments. In this study, we found
analytically and empirically that flow velocity is additive to the PWV predicted based on
pressure and material properties alone.
Although published results establish correlation between SBP or DBP and
measures of pulse wave velocity (PWV, TT, rPTT), no measure has emerged as a
robust predictor of blood pressure across the full physiologic range. The aim of this
study is to test the theory that accounting for the flow contribution to PWV based on
fundamental physics of wave propagation in nonlinear elastic arteries will improve
overall blood pressure prediction. The approach used is based on a novel mathematical
model predicting PWV, accounting for nonlinear aspects of a convective fluid
phenomena, hyperelastic constitutive relations, and finite deformation of the arterial wall
[20]. In this work, the use of peak flow to correct PWV for determination of systolic blood
pressure is proposed. To test the theory, the mean data presented in Payne et al. and
Ochiai et al. [15,16] is used. Using linear regression and the coefficient of determination,
the correlation between pressure and measured PWV, flow-corrected PWV (PWVf), and
rPTT is compared.

6.2.1 Fluid-Structure Interaction Model
The potential for estimating arterial blood pressure based on PWV has been
investigated based on statistical regression models, or empirical representation of an
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incremental isotropic elastic modulus as a function of a transmural pressure [21,22].
Models treating arteries as fluid-filled compliant thin-walled cylindrical membrane shells
have been validated using data from in vitro and in vivo studies [23,24]. Recent work
accounting for nonlinear aspects of a convective fluid phenomena, hyperelastic
constitutive relations, and finite deformation of the arterial wall-determined PWV is
associated with the forward-running wave velocity [20] as shown in equation (6.1). PWV
accounting for flow (PWVf) is a function of axial flow velocity (𝑢), wall normal
displacement nondimensionalized by vessel radius (η), blood density (𝜌), and
transmural pressure (𝑝).

1+𝜂
𝑃𝑊𝑉𝑓 = 𝑢 + √
𝑝 = 𝑢 + 𝑃𝑊𝑉𝑝
2𝜌 𝜂

(6.1)

The partial derivative p indicates sensitivity of pressure with respect to the wall normal
deflection, and it has a clear interpretation as tangent (incremental) moduli in finite
strain inelasticity. The right term of equation (6.1) presents PWVf as a superposition of a
peak flow velocity (u) and a pressure-dependent PWVp.

137

6.2.2 Flow-Corrected PWV
PWV is classically measured at the foot of the forward-moving distal pressure
wave, since estimation from the peaks, or peak-to-peak velocity, can give considerable
errors due to contamination with reflected waves [25,26]. During the diastolic cardiac
phase, the axial flow velocity is close to zero, allowing equation (6.1) to simplify to
𝑃𝑊𝑉𝑓 = 𝑃𝑊𝑉𝑝 . In both Payne et al. and Ochiai et al., the diastolic PWV is used; there
was no determination of a systolic PWV associated with peak flow and the peak of the
distal wave.
A systolic PWV can be estimated from a foot-based PWV measure accounting
for flow velocity as in equation (6.1) and a calibration based on arterial pressure and
radius. Equation (6.1) reformulated to explicitly indicate a classical PWV measurement
location for systolic and diastolic is shown in equations (6.2) and (6.3), respectively.

𝑃𝑊𝑉𝑓 = 𝑢 + √

[(1 + 𝜂)𝑝𝜂 ]𝑝𝑘
2𝜌

[(1 + 𝜂)𝑝𝜂 ]𝑓𝑡
𝑃𝑊𝑉 = √
2𝜌

(6.2)

(6.3)

This leads to a systolic PWV based on a diastolic PWV measure.

[(1 + 𝜂)𝑝𝜂 ]𝑝𝑘
𝑃𝑊𝑉𝑓 = 𝑢 + 𝑃𝑊𝑉√
[(1 + 𝜂)𝑝𝜂 ]𝑓𝑡

(6.4)

The subscripts pk and ft relate to the properties measured at the peak and foot
respectively, and PWV is measured at the foot of the forward-moving distal pressure
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wave. For linear elasticity 𝑝𝜂 = 𝑐𝑜𝑛𝑠𝑡𝑎𝑛𝑡, 𝜂 =

𝑝𝑅
𝐸ℎ

, in which E- linear elastic modulus, R-

internal radius of the vessel, h- wall thickness, equation (6.4) can be written in a
simplified form

𝑃𝑊𝑉𝑓 = 𝑢 + 𝑃𝑊𝑉√

1+
1+

𝑝𝑝𝑘 𝑅𝑝𝑘

(6.5)

𝐸ℎ
𝑝𝑓𝑡 𝑅𝑓𝑡
𝐸ℎ

The numerical result under the square root is a correction coefficient that accounts for
shifts in PWV due to transmural pressure. In this work, the correction coefficient was set
to unity since the required measurements were not recorded in the referenced papers
[4,5]. PWV is calculated by dividing the constant arterial distance by the foot-to-foot
transit time of the pressure wave with referenced lengths provided in the supplemental
section for Ochiai et al. and Payne et al.
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6.3 Methods
Although flow was not directly measured in the referenced papers, the peak flow
velocity can be estimated using measured values of ejection volume, LVET, and aortic
radius. Peak flow velocity (m/s) was calculated using the diastolic systolic aorta crosssectional area (CSA) assuming a circular cross-section, LVET, cardiac output (CO), and
heart rate (HR) [27].

𝑢=

𝐶𝑂/𝐻𝑅
⁄𝐿𝑉𝐸𝑇
𝐶𝑆𝐴

(6.6)

Left ventricular ejection time (LVET) was calculated from PEP using a conservative
fixed ratio of PEP/LVET = 1/3 [27,28], and an average aortic radius was used for each
species, human and dog [25,28]. Systolic PWV was corrected for flow, using equation
(6.5). Statistical analysis was completed to calculate the coefficient of determination (R2)
and analysis of variance (ANOVA).

6.3.1 Aortic Flow and Systolic Flow Velocity
A simple modification of (6.6) accounting for a typical profile of a time-dependent
aortic flow is presented in [29]. All distributions are topologically equivalent to a triangle,
as shown in Figure 6.32.
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Figure 6.2. Ascending Aortic Flow profile for a heart coupled to a vascular system.

The total stroke volume (SV), consisting of the amount of blood ejected by the left
ventricle in one contraction, is calculated as the following integral of flow rate Q by time

SV=∫ 𝑄(𝑡)𝑑𝑡

(6.7)

Approximating Q(t) as a triangle with a height 𝑄𝑝𝑒𝑎𝑘 = 560𝑚𝑙/𝑠 and a base Δt=0.225s,
1

arrives approximately to SV=2 𝑄𝑝𝑒𝑎𝑘 Δt=63 ml/s, instead of the exact value of 64 ml/s
presented in [31]. As it follows from (6.7), an average value of a ventricular outflow is
equal to approximately half of its peak value.
1

𝑄𝑎𝑣𝑔

𝑄𝑝𝑘 Δt 1
∫ 𝑄(𝑡)𝑑𝑡
=
=≈ 2
≈ 𝑄𝑝𝑘
Δt
Δt
2

(6.8)

Now we can present systolic velocity 𝑢𝑠 using systolic aortic flow 𝑄𝑝𝑒𝑎𝑘 and a systolic
cross section area 𝐴𝑠
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𝑢𝑠 =

𝑄𝑝𝑘
𝑄𝑎𝑣𝑔
𝑄𝑝𝑘
𝐶𝑉
= 𝑘𝑠
= 𝑘𝑠
, 𝑘𝑠 =
≈2
𝐶𝑆𝐴𝑠
𝐶𝑆𝐴𝑠
𝐶𝑆𝐴𝑠 Δt
𝑄𝑎𝑣𝑔

(6.9)

where ks represents the scale factor to convert from Qavg to Qpk.

6.3.2 Aortic and Peripheral Studies
Payne et al. modulated cardiac output in healthy male subjects (mean age: 22
years) using four drugs. Angiotensin II is a peptide hormone that causes
vasoconstriction and a decrease in CO [30]. Glyceryl trinitrate, commonly used to treat
angina, is known to decrease both CO and ejection volume. Norepinephrine released by
the sympathetic nervous system increases the force with which ventricular muscle fibers
contract and affects both cardiac output and ejection volume [31]. Salbutamol is a
vasodilator that causes a significant increase in heart rate and associated CO [32,33].
Blood pressure and PWV averages across all subjects for baseline and each
pharmaceutical manipulation were used in this analysis. Although the Payne et al. data
lacks a direct cardiac output measure, literature provides averages for baseline and
each of the pharmaceuticals as shown in Table 6.1.
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Table 6.1. Angiotensin II (ARB), Glyceryl Trinitrate (GTN), Norepinephrine (NE), Salbutamol (SAL)
CO
Note
[lpm]
Baseline

5.00

Healthy person at rest [28]

ARB

4.25

Decrease by 15% [30]

SBP
GTN

4.60

Decrease by 8% [34]

134
NE

5.60

Increase by 12% [31]

134
SAL

6.50

Increase by 30% [33,32]

122 to
141
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Table 6.2. Mean physiological measurements from Ochiai et al. [16].
SBP
DBP*
HR
PEP
LVET*
CO
TT
PWV*
Flow*
[mmHg] [mmHg] [bpm] [ms]
[ms]
[lpm] [ms]
[ms]
[m/s]

PWVf**
[m/s]

Baseline

127

77

126

72

215

1.79

74

8.1

0.7

8.8

ISO

90

47

118

67

200

1.2

88

6.8

0.6

7.4

Baseline

154

103

128

87

260

1.65

59

10.1

0.5

10.7

NTG

127

78

140

69

207

1.95

71

8.5

0.7

9.2

Baseline

129

105

126

86

260

1.62

65

9.2

0.5

9.7

HVM

79

58

127

86

260

0.75

76

7.9

0.2

8.2

Baseline

168

107

123

69

207

1.75

64

9.4

0.7

10.2

DBT

226

119

139

43

128

3.33

53

11.4

2.0

13.4

Baseline

159

104

127

80

241

1.78

62

9.7

0.6

10.2

PHE

190

132

112

98

294

1.22

50

12.0

0.4

12.4

Isoflurane (ISO), Nitroglycerine (NTG), Hypovolemia (HVM), Dobutamine (DBT), Phenylephrine (PHE),
and Baseline represent the measurement before a drug was administered. *Calculated value. **Flowcorrected PWV. DBP was calculated using the measured MAP data [16].
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SBP
[mmHg]
Baseline

Table 6.3. Mean physiological measurements from Payne et al. [15].
DBP
HR
PEP
LVET*
CO#
TT
PWV*
Flow*
[mmHg] [bpm] [ms]
[ms]
[lpm] [ms]
[ms]
[m/s]

PWVf**
[m/s]

ARB

139
156

67
82

62
60

100
105

300
315

5.00
4.25

166
150

6.0
6.7

0.6
0.5

6.7
7.2

Baseline

134

66

63

95

285

5.00

164

6.1

0.7

6.8

GTN

122

61

77

92

276

4.60

184

5.4

0.5

6.0

Baseline

141

68

61

95

285

5.00

165

6.1

0.7

6.7

NE

164

81

57

87

261

5.60

151

6.6

0.9

7.5

Baseline

151

71

66

91

273

5.00

158

6.3

0.7

7.0

SAL

153

39

125

30

81

6.50

188

5.3

1.5

6.9

Angiotensin II (ARB), Glyceryl Trinitrate (GTN), Norepinephrine (NE), Salbutamol (SAL), and Baseline
represent the measurement before a drug was administered.
*Calculated value. #Referenced values used. **Flow-corrected PWV.

For Ochiai et al., a reference inner aortic radius at diastolic and systolic of Ri=4.5,
5.4 mm respectively and length d = 0.6m for the canine aorta [35] was used for all
calculations. DBP was calculated from the measured SBP and mean arterial pressure
(MAP) using the equation:

𝐷𝐵𝑃 = 1.5𝑀𝐴𝑃 − 0.5𝑆𝐵𝑃

(6.6)

For the Payne et al. study, a human inner aortic radius at diastolic and systolic of Ri =
10.5, 12.6 mm respectively was used for all calculations [25,36]. The referenced
distance from the aortic root to the index finger of d=1.0 m was used to calculate PWV
[28].
While the PWV versus pressure curve is nonlinear [10,20,23,25], both Payne et
al. and Ochiai et al. fit a linear model using regression analysis. We have used the
same R-squared statistics to run comparisons with their published results.
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6.4 Results
To test the theory that a PWVf -based estimate of SBP is more accurate than
PWV uncorrected for flow and rPTT, we used data from both Ochiai et al. and Payne et
al. [15,16]. This data allowed comparison of the coefficient of determination across the
different physiological changes induced in the two studies and assessment of the
statistical significance.

6.4.1 Flow correction improves aortic PWV correlation with blood pressure
Measured and flow-corrected PWV and associated blood pressures for the
mongrel dog aorta study of Ochiai et al. are provided in Table 6.2. A linear regression
was performed, and the associated coefficient of determination was calculated and
compared as shown in Figure 6.3a and Figure 6.3b for PWV and PWVf respectively for
SBP. The same comparison was made for SBP and DBP (Figure 6.3c and Figure 6.3d).
For both comparisons, PWVf (equation (6.5)) significantly improves the linear fit of the
data. ANOVA showed a significant positive relationship between pressure and PWVf,
R2 = 0.75 and P < 0.0001. Multivariable ANOVA also shows a significant positive
relationship for both systolic pressure and flow to PWV, P < 0.0001. Analysis of diastolic
pressure versus PWV resulted in a significant positive relationship with R2 = 0.92 and P
< 0.01, consistent with prior studies [7,14-16,27].

Figure 6.3. PWVf measured in the aorta improves blood pressure prediction. Error bars represent the
standard deviation of PWV calculated from the referenced TT measurements from [16] and uncertainty in
measures required for calculation of flow velocity. For all figures, the systolic pressure is represented by a
circle, and diastolic pressure is represented by a square. The left side includes SBP only, while the right
side includes both pressures (SBP and DBP). a) PWV uncorrected for flow across measured SBP. b)
PWV corrected for flow velocity improves the correlation with SBP alone. c) The lowest correlation was
observed with PWV uncorrected for flow across measured pressures. d) PWV corrected for flow velocity
improves the overall correlation across all pressures. Analysis of diastolic pressure versus PWV (data not
shown) produced an R2 = 0.92.
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6.4.2 Flow correction improves peripheral PWV correlation with blood pressure
Measured and flow-corrected PWV and associated blood pressures for the
human subject study of Payne et al., with the distal PWV measurement point at the
index finger, are provided in Table 6.3. A linear regression was performed, and the
associated coefficient of determination was calculated and compared, as shown in
Figure 6.3a and Figure 6.3b, respectively for SBP. The same comparison was made for
SBP and DBP (Figure 6.3c and Figure 6.3d). For both comparisons, the PWVf equation
(6.5) significantly improves the linear fit of the data. ANOVA showed there is a
significant positive relationship between pressure and PWVf, R2=0.70 and P<0.0001.
Analysis of diastolic pressure versus PWV showed a significant positive relationship
with R2 = 0.85 and P < 0.01, consistent with prior studies [7,14-16,27]. Multivariable
ANOVA also shows there is a significant positive relationship for both systolic pressure
and flow to PWV, p < 0.01.
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Figure 6.4. PWVf measured at the finger improves blood pressure prediction. Error bars represent the
standard deviation for PWV calculated from the referenced TT measurement [15] and uncertainty in
measures required for calculation of flow velocity. For all figures, the systolic pressure is represented by a
circle, and the diastolic pressure is represented by a square. The left side includes SBP only; the right
side includes both pressures (SBP and DBP). a) PWV uncorrected for flow across measured SBP.
Salbutamol (SAL) was the farthest of any other measure from the trend line. b) PWV corrected for flow
velocity improves the correlation with SBP alone. c) The lowest correlation was observed with PWV
uncorrected for flow across measured pressures. d) PWV corrected for flow velocity improves the overall
correlation across all pressures. Analysis of diastolic pressure versus PWV (data not shown) produced
R2 = 0.85.
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6.4.3 Flow-corrected PWV provides the most robust correlation with blood pressure
It has been previously reported that the rPTT provides a stronger correlation with
SBP [15], while PWV provides a stronger correlation with DBP [15,16].
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Table 6.4. Linear correlation for rPTT, PWV, PWVf with pressure (SBP, DBP).
Payne
Ochiai Note
R2
R2
rPTT to SBP

0.39

0.59

NA

PWV to DBP

0.85

0.92

NA

SBP to SBP
PWV

0.34

0.81

No flow correction

134 f to SBP
PWV

0.88

0.92

Flow correction

134
PWV to Pressure

0.05

0.51

No flow correction

122 tof to Pressure
PWV

0.70

0.75

Flow correction

141
164

As shown in Table 6.4, there was a good correlation between PWV and DBP for both
Payne et al. and Ochiai et al. (R2 = 0.92, 0.85 respectively). However, using our PWVf
produced the highest coefficient of determination when compared with both PWV
uncorrected for flow and rPTT. It is interesting to note that Payne et al.’s peripherally
measured PWV to SBP data had the lowest R2, which may be due to the influence of
peripheral muscular arteries versus the elastic nature of the aorta.
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6.5 Discussion
The main novel contribution of the present study is the introduction of a PWVf
that improves correlation with blood pressure over both uncorrected PWV and rPTT. For
diastolic pressure prediction, PWV measured at the foot, near the diastolic point, should
be used. PWVf calculated using equation (6.5) allows correlation of PWV with SBP, with
time point measurement at the diastolic foot of the waveform, a robust measurement
point.
It has been observed in some papers that rPTT has a stronger correlation with
systolic pressure than PWV [15,16]. We believe this correlation occurs because of the
PEP component of rPTT. PEP accounts for a substantial and variable portion of rPTT,
ranging from 12 to 35% [15] and has been shown to inversely correlate with contractility
[27]. It is likely that the observed relationship between SBP and rPTT is due to this
embedded measure of contractility. For example, exercise results in increased SBP,
increased contractility, and decrease in PEP, driving an associated increase in flow
velocity that in turn increases PWV. The result is a two-fold influence on rPTT: a
decrease due to reduced PEP and shorter transit time. It was found that rPTT had an
inverse linear correlation with SBP (combined average across all subjects and drugs)
for Payne et al. and Ochiai et al. as R2 = 0.39, and R2 = 0.59, respectively. We found
that based on equation (6.5), using flow-corrected PWV produces an R2 = 0.88 and
R2 = 0.92, respectively (Payne et al., Ochiai et al.). This approach offers the strongest fit
of all the permutations considered, as seen in Table 6.4.
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In this work, equation (6.6) is used as an estimate of peak flow velocity. In other
work, aortic peak flow has been found to be ~2 times average aortic flow [29]. Using this
alternate estimate of peak flow, our R2 results improved from 0.7 to 0.87 and 0.75 to
0.85 for the Payne et al. and Ochiai et al. data, respectively. These results are
consistent with historic literature in which peak volumetric flow in relation to the aortic
pressure is most closely associated with the forward-moving systolic peak pressure
wave [25-27]. For a continuous estimation of SBP, a flow-based measure is required.
An estimate is possible using a head ballistocardiogram [35] or by using a percentage of
PWV [37].
Prior studies have recognized that compensating measured PWV with LVET may
be important [6,19]. Salvi et al. and Nurnberger et al. found that a change in ejection
time of ~40 ms (~12%) caused a change in PWV of ~1 m/s (~17%) [6,19]. Salvi et al.
[19] performed a large population study to explore the link between PWV and LVET. An
inverse linear association was found between PWV and LVET at all ages (R2=0.35,
p < 0.0001) [19]. Nurenberger considered all hemodynamic parameters (except flow
velocity) and found that at rest, only DBP and LVET correlated with PWV. In our
previous work [18], we showed that increased flow velocity was responsible for the
increase in PWV under conditions of decreasing LVET and fixed ejection volume. PWV
was substantially affected by flow velocity (~10%) and peak pressure (~2%) changes
controlled by ejection time. As represented in equation (6.5), PWVf is affected by both
flow and the physical properties of the aorta as represented by the correction
coefficient. At diastolic pressure when flow is close to zero, PWV is dominated by the
physical anisotropic properties of the aorta. At systolic pressure, the pulse wave velocity
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is also affected by flow velocity. To estimate the impact of uncertainty of the input data
upon PWVf, we performed a sensitivity analysis using a variation of +/-10% for each of
the following datasets: C0, LVET, and CSA. We have found that the R2 varied from
0.73-0.76 for the Ochiai et al. dataset and from 0.64-0.73 for the Payne et al. dataset.
Building on this work, we have developed per patient calibration to allow for the
prediction of blood pressure. For this analysis, all data is based on measures taken on a
middle-aged, healthy male, in our laboratory. The measured aortic length of ~ 0.6 m
was used to calculate PWV from the transit time measures. The first step extracts
material characteristics for an artery, using a calibration step that provides at least three
values each for blood pressure, internal radius, and wall thickness of an arterial
segment. It is assumed that wall thickness is a constant, with minimal change between
systolic and diastolic pressure. Ultrasound is used to measure the aortic diameter with
an observed variance of (±0.8𝑚𝑚). This results in a per patient blood pressure, transit
time calibration curve as shown in Figure 6.5 with an observed variance in the measure
leading to a maximum uncertainty of ~1.8%.

Figure 6.5. The patient’s transit time calibration curve created by the fully nonlinear thick wall model
described in Chapter 5, using the noninvasive extraction of the aortic material characteristics from the
ultrasound aortic radial measures and the cuff-based blood pressure measures.
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Using the calibration curve, the accuracy required to meet the Association for the
Advancement of Medical Instrumentation (AAMI) standard is analyzed. AAMI stipulates
that the mean difference between the test device and the standard shall be less than or
equal to 5 mmHg with a standard deviation of less than or equal to 8 mmHg [40]. The
transit time accuracy required to achieve the AAMI standard of ±5 𝑚𝑚𝐻𝑔 is shown in
Figure 6.6. In the range of normal diastolic pressure (80 𝑚𝑚𝐻𝑔 ± 5 𝑚𝑚𝐻𝑔), an

Figure 6.6. The transit time accuracy required to achieve the AAMI blood pressure standard ±5 𝑚𝑚𝐻𝑔.
An accuracy of 9.8 ms is required for a diastolic pressure of 80 mmHg. For a systolic pressure of 120
mmHg, an accuracy of ~5.1 ms is required. In conditions of hypertension, for a systolic pressure of 200
mmHg, an accuracy ~2.0 ms is required.

associated transit time measure of 117 ms (PWV of 5.1 m/s) with an accuracy of ~9.8

ms is required, as summarized in Table 6.5. For systolic pressure (120 𝑚𝑚𝐻𝑔 ±
5𝑚𝑚𝐻𝑔), where the slope of the calibration curve is more gradual, an associated transit
time measure of 88.6 ms (PWV of 6.7 m/s) with an accuracy of ~5.1 ms is required.
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Table 6.5. The transit time accuracy required to meet the AAMI standard.
Pressure
TT
PWV
Accuracy
[mmHg]
[ms]
[m/s]
[ms]
80

117

5.1

9.8

120

88

6.7

5.1

SBP
134

A measured PWV includes both the pressure-dependent PWV term, represented
by the calibrated model, and an additive flow velocity component. This flow velocity can
be estimated as a percentage (~20%) of PWV [37]. Using the calibrated model, at 120

mmHg the associated PWV is ~6.7 m/s. This results in an estimated flow velocity of 1.3
m/s. The slope of the calibration curve at a systolic pressure point is 0.04 (m/s)/mmHg.
Thus, in this example, ignoring flow velocity leads to an underestimate of systolic blood
pressure by ~32 mmHg for both normal and hypertensive conditions.
Data for LVET was not presented in either the Ochiai et al. or Payne et al.
studies. We recognize that under varying physiological conditions, this ratio is not
always fixed. However, a conservative fixed ratio of PEP/LVET=0.33 was used for all
drugs and baseline [27,28]. To analyze the effect of a true measure of this ratio,
salbutamol was considered, since it produced one of the largest changes in PEP (~ 65 ms from the average baseline, Table 6.3). Burgess et al. found a maximal decrease
in 𝑃𝐸𝑃⁄𝐿𝑉𝐸𝑇 of 0.070 that lasted for ~30 mins for salbutamol via a nebulizer (2.35 mg)
[32]. When we decreased the PEP/LVET ratio by this amount down to 0.27 (a 20%
reduction) for the salbutamol data, the SBP to PWVf R2 value improved to 0.92 from the
previously reported 0.88. It can be seen that salbutamol has the biggest impact on the
uncorrected R2 value in Figure 6.4a (SAL). Since salbutamol increases cardiac output
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and decreases the PEP/LVET ratio, it causes the largest flow increase from the
baseline.
The aortic PWV measure offered higher correlation than PWV measures at the
periphery. Prior studies have found a ~20% increase in PWV when measured in the
periphery (femoral-ankle) versus central measures (carotid-femoral) caused by changes
in arterial radius, thickness, and modulus of elasticity [37,38]. The correlation difference
is likely caused by drugs that affect elastic arteries differently than the muscular arteries
[17]. Nitroglycerin, for example, produces a peripheral vascular effect by relaxing the
smooth muscle. This insight supports the view that noninvasive sensors should be
placed in as close proximity to an elastic artery as possible for PWV measures to avoid
the modulation of PWV possible in the muscular arteries.
In this work, the correction coefficient was set to unity since the required
measurements were not recorded in the referenced papers [15,16]. We recognize the
physical properties of the aorta at SBP are different (less compliant) than those at DBP,
causing a faster-moving pressure wave. To estimate the impact of the correction
coefficient, referenced values [27] for both a canine and a human were substituted into
equation (6.5). The pressure to PWVf R2 values improved from 0.70 to 0.92 and 0.75 to
0.94 for the Payne et al. and Ochiai et al. datasets, respectively. It is possible for future
studies to perform per patient calibration as shown by equation (6.5) and to measure
the required aortic wall information using ultrasound. A PWVf can then be calculated
from a foot-based PWV measure that is free from errors induced by reflected waves
[25,26]. Additional studies are required to determine the advantage of this estimate and
the associated improvement in SBP prediction.
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Flow-corrected PWV significantly improves PWV correlation with SBP, which is
important for continuous cuff-less blood pressure measures. Uncorrected data could
potentially lead to unneeded treatments. For a single person tested in our laboratory, it
was found that ignoring flow velocity leads to an underestimate of systolic blood
pressure by~32 mmHg for both normal and hypertensive conditions. A key limitation of
this study is the lack of published data that includes both flow velocity and PWV.
Additional studies are required that explicitly measure aortic flow velocity along with
PWV and vessel characteristics across a broad age range, under varying physiological
conditions.
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6.6 Conclusion
Accounting for the flow contribution to PWV based on the fundamental physics of
wave propagation in nonlinear elastic arteries improves blood pressure prediction. It
was found that flow-corrected PWV correlates with SBP better than both uncorrected
PWV and rPTT, based on analysis of prior published studies with pharmaceutically
induced blood pressure shifts. We found that using peak flow velocity to correct PWV
produces robust blood pressure to PWVf correlation for peripheral (R2 = 0.70) and aortic
(R2 = 0.75) PWV measurements across the full range of physiologic pressure. Flow
correction of PWV unifies the correlation curves, enabling both SBP and DBP to be
associated with the same physical PWV measure.
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Chapter 7:

Conclusions and Future Work

Study hard what interests you most, in the most undisciplined, irreverent and original manner possible.
- Richard Feynman, Physicist and Bongo player

7.1 Summary of Contributions
The overriding goal of this work was to create a continuous noninvasive blood
pressure system. PWV and ECG are two of the physiological signals required. While
today’s wearables have integrated photoplethysmography as a way to measure heart
rate, they have yet to extend and combine the necessary measures to extract PWV.
Companies like AlivCor have created smartphone sensors that enable ECG
measurement; however, the sensors are not yet in a wearable form. In addition to these
measures, a measure of pre-ejection period and flow are required. Multiple approaches
show promise, such as the ballistocardiogram (BCG), impedance plethysmography,
inductive sensing, RF techniques such as dual-antenna nanosecond pulse near-field
sensing (NPNS), and micro-ultrasound sensors. As of this writing, none of these
techniques have been in a wearable form factor and validated across various
physiological states against a gold standard (Doppler ultrasound). The combination of
ECG, PWV, and flow measures is required in a wearable microsystem to allow for cuffless continuous non-invasive blood pressure monitoring. To provide the missing insights
in this area, we developed and validated a series of three models, each incorporating
additional complexities and nonlinearities of the arterial system.
The first model, presented in Chapter 3, was a one-dimensional nonlinear model
for pressure wave propagation in a compliant tube with a linear elastic wall filled with an
incompressible fluid. It was recognized in a number of clinical studies that both pressure
and LVET affected PWV. Using our first model and a physiologically based
electromechanical hemodynamic simulator, we studied this effect. The results indicate
an inverse quadratic relationship between ejection time and PWV, with ejection time
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dominating the PWV shifts, over those observed with changes in peak pressure. The
key insight provided by the model is that PWV is a superposition of flow velocity and a
pressure-dependent term as seen in equation (3.16). Flow velocity can dominate the
change in PWV under physiological conditions that cause a large change, such as
digestion. In our study, PWV was substantially affected by average flow velocity (~10%)
changes controlled within the physiological range of LVET. To a lesser extent, PWV
was affected by peak pressure changes alone (~2%).
The second model, presented in Chapter 4, predicted the general relationship
between PWV and BP with a rigorous account of nonlinearities in the fluid dynamics
model, blood vessel elasticity, and finite dynamic deformation of a membrane type thin
anisotropic wall. Pulse wave propagation in a compliant arterial segment is presented
within the framework of pseudoelastic deformation of biological tissue undergoing finite
deformation in thin-walled arterial segments. An essential ingredient is the dependence
of results on nonlinear aspects of the model: convective fluid phenomena, hyperelastic
constitutive relation, large deformation, and a longitudinal pre-stress load. An exact
analytical solution for PWV is presented as a function of pressure, flow, and
pseudoelastic orthotropic parameters. The key insight was that the entirely nonlinear
model achieves the best match with the experimental data. To retrieve individual
vascular information of a patient, the inverse problem of hemodynamics is presented,
calculating local orthotropic hyperelastic properties of the arterial wall. The proposed
technique can be used for non-invasive assessment of arterial elastance and blood
pressure using direct measurement of PWV, accounting for hyperelastic orthotropic
properties. This critical finding creates a non-invasive aortic calibration by using the
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(pressure, PWV) curve to extract the associated material properties of the vessel
(𝑐, 𝑎11 , 𝑎12 , 𝑎22 ). A similar calibration technique is also possible by measuring pressure
and the corresponding change in aortic radius.
The final model, presented in Chapter 5, examined the impact of the thick arterial
wall made up of three layers (intima, media, and adventitia) with different material
properties in the radial direction. We examine the accuracy of PWV prediction based on
a traditional homogeneous structural model for thin-walled arterial segments. In reality,
arteries are described as composite heterogeneous hyperelastic structures, where the
thickness dimension cannot be considered small compared to the cross-section size.
The dependence of PWV on pressure for three vessels of different thicknesses is
compared against that of a traditional thin wall model of a membrane shell interacting
with an incompressible fluid. The key insight was that a single thick layer model is
sufficient to predict PWV of an arterial segment and provides improved accuracy over
the thin wall model. For a hypertensive subject, the thick wall model provides improved
accuracy up to 8.4% in PWV prediction over its thin wall counterpart. This translates to
nearly 20% improvement in blood pressure prediction based on a PWV measure.
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In the linear and fully nonlinear model, flow velocity is additive to the classic
pressure wave, as estimated by arterial material properties. This suggests that flow
velocity correction may be important for cuff-less, non-invasive blood pressure
measures. In Chapter 6, we examined the impact of systolic flow correction of a
measure of PWV on systolic blood pressure prediction accuracy using data from two
published in vivo studies. Both studies examined the relationship between PWV and
blood pressure under pharmacological manipulation, one in mongrel dogs and the other
in healthy adult males. Systolic flow correction of the measured PWV improves the R2
correlation to systolic blood pressure from 0.81 to 0.92 for the mongrel dog study, and
from 0.34 to 0.88 for the human subjects study. The key insight is the introduction of a
flow-corrected PWV that improves correlation with systolic blood pressure over
uncorrected PWV. For diastolic pressure prediction, PWV measured at the foot should
be used. Flow-corrected PWV calculated using equation (6.5) allows correlation of PWV
with SBP, with time point measurement at the diastolic foot of the waveform, a robust
measurement point.
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7.2 Future Work
The overriding goal of this work is to create a continuous noninvasive blood
pressure system. While we have successfully advanced the science in this area, there
are still exciting areas in which to work to achieve a truly wearable device with accurate
calibration across all physiological states.
In the first linear model, we created and validated a model that shows that flow is
additive to PWV and critical for SBP prediction. There are multiple approaches that
show promise, such as the ballistocardiogram (BCG), impedance plethysmography
(IPG), inductive sensing, RF techniques such as dual-antenna nanosecond pulse nearfield sensing (NPNS), and micro-ultrasound sensors. As of this writing, none have been
created in a wearable form factor and validated across various physiological states
against a gold standard (Doppler ultrasound).
To create the complete microsystem capable of continuous monitoring of blood
pressure, it is critical to accurately sense ECG, PEP, transit time, and aortic flow. ECG
sensors are now commonly worn on the chest. Companies like MC10 have created
systems that communicate the raw signal via Bluetooth low energy to handheld devices.
Wrist-worn measures are also possible by having an electrode on the left wrist and
touching the top plate electrode with one’s right finger. Companies like AliveCor have
demonstrated this technology on a handset. The final location that is ideal for a
wearable is an ear-worn ECG [1]. This location is relatively free of motion artifacts and
is ideal for BCG and PPG.
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BCG is considered a noninvasive method to determine both aortic valve opening
and stroke volume [1,2]. PEP is extracted as the time from the ECG R-wave to the Jwave of the BCG signal. Significant research is still required to understand this measure
over various physiological states. Stroke volume can be estimated from the J-wave
amplitude. A linearly proportional relationship between J-wave amplitudes and stroke
volume is observed because the BCG recoil is directly related to the mass (or volume)
of the pumped blood [1]. Stroke volume coupled with aortic radius and LVET would
allow for flow velocity estimation.
A transit time measure is typically done from the aortic valve opening to a distal
point on the body using a PPG sensor. He et al. successfully demonstrated an earmounted system that combined ECG, BCG, and PPG [1]. This approach allowed the
extraction of transit time from the BCG J-wave to the foot of the PPG signal. Sola et al.
have also demonstrated a transit time measure on the chest [3]. They used IPG to
detect the aortic valve opening and a PPG sensor located at the aortic arch and
brachiocephalic branch point.
The challenge is to develop a microsystem that can integrate the sensors and
algorithms into a single device or devices that are accurate, discrete, and wearable. The
location and system will depend heavily on the use case and frequency required for
sampling the sensors. The system will then need to be refined and validated across
numerous IRB studies.
For the first time in our history, wearable devices are collecting meaningful
physiological data and digitally storing them to the Cloud. Our work has provided the
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theoretical framework that may enable cuff-less noninvasive blood pressure (CNIBP)
monitoring. This advancement is exciting because information like heart rate, ECG,
CNIBP, activity level, and weight are continuously being stored for many people. The list
of clinically meaningful and wearable sensors is constantly growing and improving. The
ability to use this information for data mining, and look for health trends, I believe, will
lead to medical breakthroughs never before possible. It is my hope that this will truly
democratize medicine.
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Appendix A:

Noninvasive Blood Pressure – Phase I

IRB Study Proposal, for work conducted at Rochester General Hospital
Sreedevi Chennupati, MD (RGH), David Borkholder, PhD (RIT), Jeffrey Lillie, MS (RIT),
Stephen Silver, MD (RGH)

Social and Scientific Value
Hypertension is an important risk factor for cardiovascular diseases, such as
cardiac failure, stroke and coronary artery disease. The incidence of hypertension in the
United States was about 31% according to the NHANES data from 1999-2000.1 The
increase in prevalence beyond the expected rate is likely related to increasing incidence
of obesity and the aging of the population.1,2 The number of persons with hypertension
worldwide was 972 million in 2000 and is anticipated to increase to 1.56 billion by the
year 20253.
Adding to the burden of hypertension further are factors that confound office
blood pressure readings, the data on which physicians mostly rely for making treatment
decisions. White coat hypertension, where the office blood pressure readings are higher
than ambulatory readings, is present in nearly 21% of the population.4 Though overall,
white coat hypertension causes less morbidity than sustained hypertension, it still needs
to be treated, and may result in excess medication usage, given the erroneously high
office blood pressure readings.5
Masked hypertension is a relatively new entity, where office blood pressure
readings are deceptively low and ambulatory blood pressure readings are high. The
incidence of masked hypertension is about 19% among adults when determined using
self or ambulatory blood pressure readings. Their cardiovascular risk seems
comparable to patients with recognized hypertension.6 Failure to recognize the
presence of masked hypertension may result in delayed diagnosis of hypertension
and/or hypertension that is inadequately treated.
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The gold standard for blood pressure measurement is the intra arterial
measurement of blood pressure, whose invasive nature renders it impractical for routine
use. The invention of aneroid sphygmomanometers has facilitated repetitive blood
pressure measurements in ambulatory and outpatient settings. The current
recommendation with this machine, is to check blood pressure in the same arm
repeated at least twice, with additional readings if the difference is 5 mmHg or greater.
Blood pressure readings are influenced by the condition of the machine and operator
characteristics such as, but not limited to, proper method, end-digit preference and
selective recording of desirable readings.7 Optimal recording of blood pressure as
described above is less often practiced than desired, given the time constraints of
modern medical practice. A study in 2006 showed that aneroid blood readings were
inaccurate when compared to intra arterial blood pressure readings performed at the
same time, regardless of BMI.8 An automated and more accurate method of blood
pressure measurement that eliminates operator introduced error in measurement, and
can be office based and ambulatory can potentially enhance treatment of hypertension.
There is a growing body of research on non-invasive, continuous blood pressure
(BP) monitoring techniques that do not rely on an occlusive cuff. These techniques
include external pressure sensors, near infrared imaging, ultrasound, and
photoplethysmography (PPG). While all these methods have limitations, the
photoplethysmographic (PPG) technique offers the greatest potential for true continuous
monitoring of BP in a form that facilitates unrestricted ambulatory movement. The small
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form factor is less cumbersome to carry, and facilitates use in outpatient and ambulatory
settings. However, accuracy and calibration remain an issue.
Historically, the methods that used PPG for blood pressure measurement relied
on the relationship between pressure and pulse wave velocity in the arteries.
Frequently, the time period between the R-wave of an EKG recording and arrival of the
resultant pulse at a peripheral point obtained via PPG are recorded. Based on this
data, pulse wave velocity is calculated, and DBP and SBP are derived using a
regression equation. The results from this approach show modest correlation to systolic
blood pressure (SBP) but correlate poorly with diastolic blood pressure (DBP)9.
It is hypothesized that this is due to
1. Difference in vascular compliance through out the vascular tree especially when
using blood vessels of different caliber and physical characteristics
2. use of a single transit time measurement for determination of both SBP and DBP
which are influenced and are dependent on different factors
3. and the inclusion of pre-ejection period (PEP) in the transit time calculation while this
period precedes pulse transmission into the arteries. Since the fundamental equations
are based on pulse wave velocity in the arteries, inclusion of PEP represents an error
term.
An alternate approach utilizes two PPG measurements on a single artery (most
commonly the radial artery). However, variable sensor coupling impacts the shape of
the waveform there by making consistent measurement of time difference difficult.
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The proposed work will examine two approaches to mitigate the challenges described
above with non-invasive sensors. Data will be simultaneously collected for both
approaches with occlusive-cuff BP measurements collected for comparison.
Approach 1: The Electrocardiogram (EKG), phonocardiogram (recording of heart
sounds), and ear PPG will be used to allow determination of PEP and the true transit
time. This true transit time will be correlated with DBP, while SBP will be correlated with
PEP.
Approach 2: PPG signals will be measured on both ears, and waveforms recorded.
The time difference between arrivals of the foot of the waveform at both ears will be
correlated to DBP; and the time difference between the arrivals of the peak of the
waveform at both ears will be correlated to SBP. This approach fundamentally relies on
the fact that from the origin of the right brachiocephalic artery, the distance to left ear
(via the aortic arch, left common carotid and then left external carotid arteries) is greater
than the distance to right ear from the heart (via the brachiocephalic and right common
carotid and then external carotid arteries) which then results in differences in pulse
transit time, assuming the pulse velocity is the same in both branches. Since the pulse
wave velocity is related to arterial elasticity, which in turn is correlated with pressure in
the system, the time differences at the foot and peak of the PPG waveforms can be
used to estimate DBP and SBP respectively. It may allow for beat to beat pressure
readings to be accurately recorded.
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During both approaches, participants will be asked to assume different positions, and
recordings using the sphygmomanometer and PPG based method will be obtained in all
these positions. The positions include—supine, head of bed elevated at 45 degrees,
sitting and standing.

Public Dissemination of Trial Results
The results may be disseminated in summary form through conferences and/or
journal publications.

Objective of the Study
This study will provide adequate data from a clinical population for preliminary
validation of the two approaches described above. Subsequent work will involve
development of a microelectrode based system with wireless sensor nodes for noninvasive, continuous, ambulatory monitoring of blood pressure without the use of an
occlusive cuff.

Outcomes
Study results will be compared to blood pressure measures obtained with an
aneroid sphygmomanometer and/or intra arterial measurements when available. BP
accuracy will be compared against the Association for the Advancement of Medical
Instrumentation (AAMI) standards for noninvasive arterial blood pressure measurement
(maximal mean difference and standard deviation from at least 85 patients should not
exceed 5±8 mmHg from a reference method).

Sample Size
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Sample size was chosen to provide a reasonably large dataset for testing the current
concept, as this is a pilot study, meant to calibrate the PPG based device. The sample
size is not driven by statistics, as there is no base line data available to estimate
variance.
We expect to have 3 groups of 50 participants each.
Group I: To be recruited from an outpatient setting from the Rochester General Health
System (RGHS).
Group II: To be recruited from those scheduled for a cardiac stress test either at
inpatient or outpatient units belonging to the RGHS.
Group III: To be recruited from those scheduled to have a coronary angiogram at the
Rochester General Hospital.
Randomization – Sequence Generation
No randomization is required.
Randomization – Allocation Concealment
No randomization is required.

Randomization Implementation
No randomization is required.

Blinding
Blinding is not applicable to this study.
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Statistical Methods
Group comparisons are not planned at this time since this is not the aim of the proposed
study.
Fair Subject Selection – Recruitment of Participants
Participants will be recruited from outpatient or inpatient settings belonging to RGHS.
Exclusion criteria
Less than 18 years of age, pregnancy, severe cardiac disease, severe COPD, severe
peripheral vascular disease, inability to tolerate change in position as described above,
inability to follow instructions in English, impaired cognitive or functional status.
Favorable Risk-Benefit Ratio – Interventions Offering the Prospect of Health
Related Benefit
Participants receive no direct benefit from participating in the study. But, an easier and
accurate method of blood pressure measurement method may result in better BP
control and resultant benefits accrue to society in general.

Interventions Performed Solely to Answer the Research Questions
1. Collection of EKG, phonocardiogram, two ear PPG, and cuff-based BP from
individuals participating in the study in an out patient, non-stress test related
setting. This data may be obtained on two separate occasions, and in different
body positions as mentioned earlier in the protocol. This data is required to test
the proposed approach for non-invasive, cuff-less blood pressure monitoring.
2. Collection of two ear PPG, EKG and phonocardiogram (wherever possible) data
on patients undergoing cardiology stress testing. This data is required to test the
proposed approach for non-invasive, cuff-less blood pressure monitoring under
exercise conditions.

180

3. Collection of two-ear PPG, EKG and phonocardiogram (wherever possible) data
on patients undergoing cardiac catheterization procedures. This data is required
to test the proposed approach for non-invasive, cuff-less blood pressure
monitoring.

Clinical Balance
There is no intervention performed as part of the study.
Respect for Potential and Enrolled Subjects – Trial Monitoring Plan
Not applicable, as the study involves only obtaining measurements and does not involve
any intervention, medical or surgical.

Communication of Protocol Changes and Trial Monitoring
Not applicable, as the study involves only obtaining measurements and does not involve
any intervention, medical or surgical.
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Appendix B:
Noninvasive Blood Pressure
Measurement on a Stationary Recumbent
Bicycle
IRB Proposal, for work conducted at Rochester Institute of Technology

Social and Scientific Value
Hypertension is an important risk factor for cardiovascular diseases, such as
cardiac failure, stroke and coronary artery disease. The incidence of hypertension in the
United States was about 31% according to the NHANES data from 1999-2000.1 The
increase in prevalence beyond the expected rate is likely related to increasing incidence
of obesity and the aging of the population.1,2 The number of persons with hypertension
worldwide was 972 million in 2000 and is anticipated to increase to 1.56 billion by the
year 20253.
Adding to the burden of hypertension further are factors that confound office
blood pressure readings, the data on which physicians mostly rely for making treatment
decisions. White coat hypertension, where the office blood pressure readings are higher
than ambulatory readings, is present in nearly 21% of the population.4 Though overall,
white coat hypertension causes less morbidity than sustained hypertension, it still needs
to be treated, and may result in excess medication usage, given the erroneously high
office blood pressure readings.5
Masked hypertension is a relatively new entity, where office blood pressure
readings are deceptively low and ambulatory blood pressure readings are high. The
incidence of masked hypertension is about 19% among adults when determined using
self or ambulatory blood pressure readings. Their cardiovascular risk seems
comparable to patients with recognized hypertension.6 Failure to recognize the
presence of masked hypertension may result in delayed diagnosis of hypertension
and/or hypertension that is inadequately treated.
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The gold standard for blood pressure measurement is the intra arterial
measurement of blood pressure, whose invasive nature renders it impractical for routine
use. The invention of aneroid sphygmomanometers has facilitated repetitive blood
pressure measurements in ambulatory and outpatient settings. The current
recommendation with this machine, is to check blood pressure in the same arm
repeated at least twice, with additional readings if the difference is 5 mmHg or greater.
Blood pressure readings are influenced by the condition of the machine and operator
characteristics such as, but not limited to, proper method, end-digit preference and
selective recording of desirable readings.7 Optimal recording of blood pressure as
described above is less often practiced than desired, given the time constraints of
modern medical practice. A study in 2006 showed that aneroid blood readings were
inaccurate when compared to intra arterial blood pressure readings performed at the
same time, regardless of BMI.8 An automated and more accurate method of blood
pressure measurement that eliminates operator introduced error in measurement, and
can be office based and ambulatory can potentially enhance treatment of hypertension.
There is a growing body of research on non-invasive, continuous blood pressure
(BP) monitoring techniques that do not rely on an occlusive cuff. These techniques
include external pressure sensors, near infrared imaging, ultrasound, and
photoplethysmography (PPG). While all these methods have limitations, the
photoplethysmographic (PPG) technique offers the greatest potential for true continuous
monitoring of BP in a form that facilitates unrestricted ambulatory movement. The small
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form factor is less cumbersome to carry, and facilitates use in outpatient and ambulatory
settings. However, accuracy and calibration remain an issue.
Historically, the methods that used PPG for blood pressure measurement relied
on the relationship between pressure and pulse wave velocity in the arteries.
Frequently, the time period between the R-wave of an EKG recording and arrival of the
resultant pulse at a peripheral point obtained via PPG are recorded. Based on this
data, pulse wave velocity is calculated, and DBP and SBP are derived using a
regression equation. The results from this approach show modest correlation to systolic
blood pressure (SBP) but correlate poorly with diastolic blood pressure (DBP)9.
The proposed work will examine an approach to mitigate the challenges described
above with non-invasive sensors. Data will be collected necessary to measure BP
using the new approach and compared with occlusive-cuff BP measurements.

During this approach, participants will be asked to ride a stationary recumbent bicycle
for 35 minutes with the difficulty level increased every 5 minutes for the first 25 minutes,
followed by 2 cool down steps where the level is decreased. Recordings using the
sphygmomanometer and PPG based method will be obtained each time after 3 minutes
at a particular resistance level. The participants will remain on the stationary recumbent
bicycle for the complete length of the test, approximately 45 minutes. Participants will be
asked back to repeat the study in approximately 1 week.
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Resistance level 1 feels like you are riding on a flat surface with no head wind.
Resistance level 5 feels like you are riding up a moderate incline or into a 15-20 MPH
head wind. Resistance levels 2-4 are linearly increasing in difficulty between these two
extremes. In general it will cause your heart rate to increase, as it would during
moderate aerobic exercise. You should be able to carry on a conversation at all of the
levels of this testing.

Public Dissemination of Trial Results
The results may be disseminated in summary form through conferences and/or
journal publications.

Objective of the Study
This study will provide adequate data from a clinical population for preliminary
validation of the approach described above. Subsequent work will involve development
of a microelectrode based system with wireless sensor nodes for non-invasive,
continuous, ambulatory monitoring of blood pressure without the use of an occlusive
cuff.

Outcomes
Study results will be compared to blood pressure measures obtained with an
aneroid sphygmomanometer. BP accuracy will be compared against the Association for
the Advancement of Medical Instrumentation (AAMI) standards for noninvasive arterial
blood pressure measurement (maximal mean difference and standard deviation from at
least 85 patients should not exceed 5±8 mmHg from a reference method).
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Sample Size
Sample size was chosen to provide a reasonably large dataset for testing the current
concept, as this is a pilot study, meant to calibrate the PPG based device. The sample
size is not driven by statistics, as there is no base line data available to estimate
variance. We expect to have 1 group of 30 participants. Group I: To be recruited from
Rochester Institute of Technology students or faculty. (RIT).
Randomization – Sequence Generation
No randomization is required.
Randomization – Allocation Concealment
No randomization is required.

Randomization Implementation
No randomization is required.

Blinding
Blinding is not applicable to this study.

Statistical Methods
Group comparisons are not planned at this time since this is not the aim of the proposed
study.
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Fair Subject Selection – Recruitment of Participants
Participants will be recruited from students or faculty on the Rochester Institute of
Technology Campus
Exclusion criteria
Less than 18 years of age, pregnancy, severe cardiac disease, severe COPD, severe
peripheral vascular disease, inability to tolerate change in position as described above,
inability to follow instructions in English, impaired cognitive or functional status.
Favorable Risk-Benefit Ratio – Interventions Offering the Prospect of Health
Related Benefit
Participants receive no direct benefit from participating in the study. But, an easier and
accurate method of blood pressure measurement method may result in better BP
control and resultant benefits accrue to society in general.

Interventions Performed Solely to Answer the Research Questions
4. Collection of EKG, phonocardiogram, two ear PPG, and cuff-based BP from
individuals participating in the study in an out patient, non-stress test related
setting. This data may be obtained on two separate occasions, and in different
body positions as mentioned earlier in the protocol. This data is required to test
the proposed approach for non-invasive, cuff-less blood pressure monitoring.
Clinical Balance
There is no intervention performed as part of the study.
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Respect for Potential and Enrolled Subjects – Trial Monitoring Plan
Not applicable, as the study involves only obtaining measurements and does not involve
any intervention, medical or surgical.

Communication of Protocol Changes and Trial Monitoring
Not applicable, as the study involves only obtaining measurements and does not involve
any intervention, medical or surgical.

Monitoring Equipment Approved for Use with Humans
The biopac system will be used to measure PPG and ECG on the subjects. Biopac
systems provided an EC declaration of conformity with the equipment.
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